UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Author | Type
Jump to: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Number of items: 358.

A

Alison, MR; Guppy, NJ; Lim, SML; Nicholson, LJ; (2010) Finding cancer stem cells: are aldehyde dehydrogenases fit for purpose? The Journal of Pathology , 222 (4) pp. 335-344. 10.1002/path.2772.

Alpendurada, F; Carpenter, JP; Deac, M; Kirk, P; Walker, JM; Porter, JB; Banya, W; (2010) Relation of myocardial T2*to right ventricular function in thalassaemia major. EUR HEART J , 31 (13) 1648 - 1654. 10.1093/eurheartj/ehq106.

Altshuler, D; Durbin, RM; Abecasis, GR; Bentley, DR; Chakravarti, A; Clark, AG; Collins, FS; (2010) A map of human genome variation from population-scale sequencing. NATURE , 467 (7319) pp. 1061-1073. 10.1038/nature09534.

Andreana, L; Isgro, G; Garcovich, M; Burroughs, AK; Dhillon, AP; Luong, TV; (2010) DOES HIGH MAGNIFICATION COMPARED TO CONVENTIONAL MAGNIFICATION COLLAGEN PROPORTIONATE AREA ALTER ITS SENSITIVITY IN ASSESSING THE AMOUNT OF FIBROSIS IN CHRONIC LIVER DISEASE? In: JOURNAL OF HEPATOLOGY. (pp. S202 - S202). ELSEVIER SCIENCE BV

Andreana, L; Isgro, G; Grillo, F; Hall, A; Burroughs, AK; Dhillon, AP; Luong, T; (2010) DOES HIGH MAGNIFICATION COMPARED WITH CONVENTIONAL MAGNIFICATION COLLAGEN PROPORTIONATE AREA ALTER ITS SENSITIVITY IN ASSESSING THE AMOUNT OF FIBROSIS IN CHRONIC LIVER DISEASE? In: GUT. (pp. A69 - A69). B M J PUBLISHING GROUP

Austwick, MR; Clark, B; Mosse, CA; Johnson, K; Chicken, DW; Somasundaram, SK; Calabro, KW; (2010) Scanning elastic scattering spectroscopy detects metastatic breast cancer in sentinel lymph nodes. J BIOMED OPT , 15 (4) , Article 047001. 10.1117/1.3463005. Gold open access

Ayto, RM; Hughes, DA; Jeevaratnam, P; Rolles, K; Burroughs, AK; Mistry, PK; Mehta, AB; (2010) Long-Term Outcomes of Liver Transplantation in Type 1 Gaucher Disease. AM J TRANSPLANT , 10 (8) 1934 - 1939. 10.1111/j.1600-6143.2010.03168.x.

B

Bartesaghi, S; Betts-Henderson, J; Cain, K; Dinsdale, D; Zhou, XS; Karlsson, A; Salomoni, P; (2010) Loss of thymidine kinase 2 alters neuronal bioenergetics and leads to neurodegeneration. HUM MOL GENET , 19 (9) 1669 - 1677. 10.1093/hmg/ddq043.

Bates, AW; (2010) The Anatomy of Robert Knox. [Book]. Sussex Academic Pr

Bazeos, A; Marin, D; Reid, AG; Gerrard, G; Milojkovic, D; May, PC; de Lavallade, H; (2010) hOCT1 transcript levels and single nucleotide polymorphisms as predictive factors for response to imatinib in chronic myeloid leukemia. LEUKEMIA , 24 (6) pp. 1243-1245. 10.1038/leu.2010.86.

Beck, S; (2010) Taking the measure of the methylome. NAT BIOTECHNOL , 28 (10) 1026 - 1028. 10.1038/nbt1010-1026.

Bejugam, M; Gunaratnam, M; Müller, S; Sanders, DA; Sewitz, S; Fletcher, JA; Neidle, S; (2010) Targeting the c-Kit Promoter G-quadruplexes with 6-Substituted Indenoisoquinolines. ACS Med Chem Lett , 1 (7) pp. 306-310. 10.1021/ml100062z.

Bell, C.G.; Teschendorff, A.E.; Rakyan, V.K.; Maxwell, A.P.; Beck, S.; Savage, D.A.; (2010) Genome-wide DNA methylation analysis for diabetic nephropathy in type 1 diabetes mellitus. BMC Medical Genomics , 3 , Article 33. 10.1186/1755-8794-3-33. Green open access
file

Bell, CG; Beck, S; (2010) The epigenomic interface between genome and environment in common complex diseases. BRIEF FUNCT GENOMICS , 9 (5-6) 477 - 485. 10.1093/bfgp/elq026.

Bell, CG; Finer, S; Lindgren, CM; Wilson, GA; Rakyan, VK; Teschendorff, AE; Akan, P; (2010) Integrated Genetic and Epigenetic Analysis Identifies Haplotype-Specific Methylation in the FTO Type 2 Diabetes and Obesity Susceptibility Locus. PLOS ONE , 5 (11) , Article e14040. 10.1371/journal.pone.0014040. Green open access
file

Bell, CG; Teschendorff, AE; Rakyan, VK; Maxwell, AP; Beck, S; Savage, DA; (2010) Genome-wide DNA methylation analysis for diabetic nephropathy in type 1 diabetes mellitus. BMC Medical Genomics , 3 , Article 33. 10.1186/1755-8794-3-33. Green open access
filefilefile

Bennett, K; James, C; Hussain, K; (2010) Pancreatic beta-cell K-ATP channels: Hypoglycaemia and hyperglycaemia. REV ENDOCR METAB DIS , 11 (3) 157 - 163. 10.1007/s11154-010-9144-2.

Berro, M; Mayor, NP; Maldonado-Torres, H; Cooke, L; Kusminsky, G; Marsh, SGE; Madrigal, AA; (2010) Association of functional polymorphisms of the transforming growth factor B1 gene with survival and graft-versus-host disease after unrelated donor hematopoietic stem cell transplantation. pp. 276-283.

Berro, M; Mayor, NP; Maldonado-Torres, H; Cooke, L; Kusminsky, G; Marsh, SGE; Madrigal, JA; (2010) Association of functional polymorphisms of the transforming growth factor B1 gene with survival and graft-versus-host disease after unrelated donor hematopoietic stem cell transplantation. HAEMATOL-HEMATOL J , 95 (2) 276 - 283. 10.3324/haematol.2009.010835. Gold open access

Betts-Henderson, J; Bartesaghi, S; Crosier, M; Lindsay, S; Chen, HL; Salomoni, P; Gottlob, I; (2010) The nystagmus-associated FRMD7 gene regulates neuronal outgrowth and development. HUM MOL GENET , 19 (2) 342 - 351. 10.1093/hmg/ddp500.

Bilanges, B; Vanhaesebroeck, B; (2010) A new tool to dissect the function of p70 S6 kinase. Biochem J , 431 (2) e1-e3. 10.1042/BJ20101445.

Bjedov, I; Toivonen, JM; Kerr, F; Slack, C; Jacobson, J; Foley, A; Partridge, L; (2010) Mechanisms of Life Span Extension by Rapamycin in the Fruit Fly Drosophila melanogaster. Cell Metabolism , 11 (1) 35 - 46. 10.1016/j.cmet.2009.11.010. Green open access
file

Bodin, K; Ellmerich, S; Kahan, MC; Tennent, GA; Loesch, A; Gilbertson, JA; Hutchinson, WL; (2010) Antibodies to human serum amyloid P component eliminate visceral amyloid deposits. NATURE , 468 (7320) 93 - 97. 10.1038/nature09494.

Bonnet, J; Wang, YH; Spedale, G; Atkinson, RA; Romier, C; Hamiche, A; Pijnappel, WW; (2010) The structural plasticity of SCA7 domains defines their differential nucleosome-binding properties. EMBO Rep , 11 (8) pp. 612-618. 10.1038/embor.2010.98.

Boss, DS; Schwartz, GK; Middleton, MR; Amakye, DD; Swaisland, H; Midgley, RS; Ranson, M; (2010) Safety, tolerability, pharmacokinetics and pharmacodynamics of the oral cyclin-dependent kinase inhibitor AZD5438 when administered at intermittent and continuous dosing schedules in patients with advanced solid tumours. ANN ONCOL , 21 (4) 884 - 894. 10.1093/annonc/mdp377.

Bracci, PM; Skibola, CF; Conde, L; Halperin, E; Lightfoot, T; Smith, A; Paynter, RA; (2010) Chemokine polymorphisms and lymphoma: a pooled analysis. Leuk Lymphoma , 51 (3) pp. 497-506. 10.3109/10428190903518337.

Braconi, C; Valeri, N; Gasparini, P; Huang, NY; Taccioli, C; Nuovo, G; Suzuki, T; (2010) Hepatitis C Virus Proteins Modulate MicroRNA Expression and Chemosensitivity in Malignant Hepatocytes. CLIN CANCER RES , 16 (3) 957 - 966. 10.1158/1078-0432.CCR-09-2123.

Brada, M; Stenning, S; Gabe, R; Thompson, LC; Levy, D; Rampling, R; Erridge, S; (2010) Temozolomide Versus Procarbazine, Lomustine, and Vincristine in Recurrent High-Grade Glioma. JOURNAL OF CLINICAL ONCOLOGY , 28 (30) 4601 - 4608. 10.1200/JCO.2009.27.1932.

Branchini, BR; Ablamsky, DM; Davis, AL; Southworth, TL; Butler, B; Fan, F; Jathoul, AP; (2010) Red-emitting luciferases for bioluminescence reporter and imaging applications. ANAL BIOCHEM , 396 (2) 290 - 297. 10.1016/j.ab.2009.09.009.

Breckpot, K; Escors, D; Arce, F; Lopes, L; Karwacz, K; Van Lint, S; Keyaerts, M; (2010) HIV-1 Lentiviral Vector Immunogenicity Is Mediated by Toll-Like Receptor 3 (TLR3) and TLR7. J VIROL , 84 (11) 5627 - 5636. 10.1128/JVI.00014-10.

Brooks, SP; Coccia, M; Tang, HR; Kanuga, N; Machesky, LM; Bailly, M; Cheetham, ME; (2010) The Nance-Horan syndrome protein encodes a functional WAVE homology domain (WHD) and is important for co-ordinating actin remodelling and maintaining cell morphology. HUM MOL GENET , 19 (12) 2421 - 2432. 10.1093/hmg/ddq125.

Bruneau, J; Canioni, D; Renand, A; Marafioti, T; Paterson, JC; Martin-Garcia, N; Gaulard, P; (2010) Regulatory T-cell depletion in angioimmunoblastic T-cell lymphoma. Am J Pathol , 177 (2) pp. 570-574. 10.2353/ajpath.2010.100150.

Brunetto, AT; Kristeleit, RS; de Bono, JS; (2010) Early oncology clinical trial design in the era of molecular-targeted agents. Future Oncol , 6 (8) pp. 1339-1352. 10.2217/fon.10.92.

Brunetto, AT; Sarker, D; Papadatos-Pastos, D; Fehrmann, R; Kaye, SB; Johnston, S; Allen, M; (2010) A retrospective analysis of clinical outcome of patients with chemo-refractory metastatic breast cancer treated in a single institution phase I unit. Br J Cancer , 103 (5) pp. 607-612. 10.1038/sj.bjc.6605812.

Burnett, AK; Hills, RK; Green, C; Jenkinson, S; Koo, K; Patel, Y; Guy, C; (2010) The impact on outcome of the addition of all-trans retinoic acid to intensive chemotherapy in younger patients with nonacute promyelocytic acute myeloid leukemia: overall results and results in genotypic subgroups defined by mutations in NPM1, FLT3, and CEBPA. BLOOD , 115 (5) 948 - 956. 10.1182/blood-2009-08-236588.

Butcher, LM; Beck, S; (2010) AutoMeDIP-seq: A high-throughput, whole genome, DNA methylation assay. METHODS , 52 (3) 223 - 231. 10.1016/j.ymeth.2010.04.003. Gold open access

C

Cain, RJ; Vanhaesebroeck, B; Ridley, AJ; (2010) The PI3K p110alpha isoform regulates endothelial adherens junctions via Pyk2 and Rac1. J Cell Biol , 188 (6) pp. 863-876. 10.1083/jcb.200907135.

Cappellini, MD; Elalfy, M; El-Beshlawy, A; Kattamis, A; Chan, LL; Li, C; Lin, KH; (2010) EFFICACY OF DEFERASIROX IN PATIENTS WITH THALASSAEMIA MAJOR IS NOT AFFECTED BY A HISTORY OF HEPATITIS B OR C. In: HAEMATOLOGICA-THE HEMATOLOGY JOURNAL. (pp. 718 - 719). FERRATA STORTI FOUNDATION Gold open access

Cappellini, MD; Porter, J; El-Beshlawy, A; Li, CK; Seymour, JF; Elalfy, M; Gattermann, N; (2010) Tailoring iron chelation by iron intake and serum ferritin: the prospective EPIC study of deferasirox in 1744 patients with transfusion-dependent anemias. HAEMATOL-HEMATOL J , 95 (4) 557 - 566. 10.3324/haematol.2009.014696. Gold open access

Carpenter, B; Haque, T; Dimopoulou, M; Atkinson, C; Roughton, M; Grace, S; Denovan, S; (2010) Incidence and Dynamics of Epstein-Barr Virus Reactivation After Alemtuzumab-Based Conditioning for Allogeneic Hematopoietic Stem-Cell Transplantation. TRANSPLANTATION , 90 (5) 564 - 570. 10.1097/TP.0b013e3181e7a3bf.

Carpenter, JP; Alpendurada, F; Deac, M; Maceira, A; Garbowski, M; Kirk, P; Walker, JM; (2010) Right ventricular volumes and function in thalassemia major patients in the absence of myocardial iron overload. Journal of Cardiovascular Magnetic Resonance , 12 , Article 24. 10.1186/1532-429X-12-24. Green open access
file

Castleton, AZ; Brazma, D; Howard-Reeves, J; Chanalaris, A; Glanville, J; Nizetic, D; Chakraverty, R; (2010) Genome gains at chromosome 21q21/22 segment leads to co-amplification of Down Syndrome Critical Regions and known oncogenes in a case of donor cell-derived acute myeloid leukaemia following allogeneic sex mismatched umbilical cord blood transplantation for chronic myeloid leukaemia. BRIT J HAEMATOL , 151 (3) 285 - 288. 10.1111/j.1365-2141.2010.08350.x.

Chakraverty, R; Orti, G; Roughton, M; Shen, J; Fielding, A; Kottaridis, P; Milligan, D; (2010) Impact of in vivo alemtuzumab dose before reduced intensity conditioning and HLA-identical sibling stem cell transplantation: pharmacokinetics, GVHD, and immune reconstitution. BLOOD , 116 (16) 3080 - 3088. 10.1182/blood-2010-05-286856.

Chapman, MH; Kajihara, M; Borges, G; O'Beirne, J; Patch, D; Dhillon, AP; Crozier, A; (2010) Severe, Acute Liver Injury and Khat Leaves. NEW ENGL J MED , 362 (17) 1642 - 1644.

Chavda, S; Babu, B; Yanow, SK; Jardim, A; Spithill, TW; Kiakos, K; Kluza, J; (2010) A novel achiral seco-cyclopropylpyrido[e]indolone (CPyI) analog of CC-1065 and the duocarmycins: Synthesis, DNA interactions, in vivo anticancer and anti-parasitic evaluation. BIOORGAN MED CHEM , 18 (14) 5016 - 5024. 10.1016/j.bmc.2010.05.078.

Chavda, S; Mulder, K; Brown, T; Mackay, H; Babu, B; Westrate, L; Ferguson, A; (2010) DNA Recognition: Design, Synthesis and Biophysical Characteristics of Pyrrole(H) Based Polyamides. MED CHEM , 6 (3) 150 - 158.

Ciau-Uitz, A; Pinheiro, P; Gupta, R; Enver, T; Patient, R; (2010) Tel1/ETV6 Specifies Blood Stem Cells through the Agency of VEGF Signaling. DEVELOPMENTAL CELL , 18 (4) pp. 569-578. 10.1016/j.devcel.2010.02.009.

Cohen, H; Machin, SJ; (2010) Antithrombotic treatment failures in antiphospholipid syndrome: the new anticoagulants? LUPUS , 19 (4) 486 - 491. 10.1177/0961203310361355.

Conde, L; Halperin, E; Akers, NK; Brown, KM; Smedby, KE; Rothman, N; Nieters, A; (2010) Genome-wide association study of follicular lymphoma identifies a risk locus at 6p21.32. Nat Genet , 42 (8) pp. 661-664. 10.1038/ng.626.

Cooley, S; Weisdorf, DJ; Guethlein, LA; Klein, JP; Wang, T; Le, CT; Marsh, SGE; (2010) Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia. BLOOD , 116 (14) pp. 2411-2419. 10.1182/blood-2010-05-283051.

Cornils, H; Stegert, MR; Hergovich, A; Hynx, D; Schmitz, D; Dirnhofer, S; Hemmings, BA; (2010) Ablation of the Kinase NDR1 Predisposes Mice to the Development of T Cell Lymphoma. SCI SIGNAL , 3 (126) , Article ra47. 10.1126/scisignal.2000681.

Cross, TJS; Calvaruso, V; Foxton, MR; Manousou, P; Quaglia, A; Grillo, F; Dhillon, AP; (2010) A simple, noninvasive test for the diagnosis of liver fibrosis in patients with hepatitis C recurrence after liver transplantation. J VIRAL HEPATITIS , 17 (9) 640 - 649. 10.1111/j.1365-2893.2009.01222.x.

Cross, TJS; Calvaruso, V; Maimone, S; Carey, I; Chang, TP; Pleguezuelo, M; Manousou, P; (2010) Prospective comparison of Fibroscan, King's score and liver biopsy for the assessment of cirrhosis in chronic hepatitis C infection. J VIRAL HEPATITIS , 17 (8) 546 - 554. 10.1111/j.1365-2893.2009.01210.x.

D

Daghistani, M; Marin, D; Khorashad, JS; Wang, L; May, PC; Paliompeis, C; Milojkovic, D; (2010) EVI-1 oncogene expression predicts survival in chronic-phase CML patients resistant to imatinib treated with second-generation tyrosine kinase inhibitors. BLOOD , 116 (26) pp. 6014-6017. 10.1182/blood-2010-01-264234.

Dalloul, RA; Long, JA; Zimin, AV; Aslam, L; Beal, K; Blomberg, LEANN; Bouffard, P; (2010) Multi-platform next-generation sequencing of the domestic turkey (Meleagris gallopavo): genome assembly and analysis. PLoS Biol , 8 (9) 10.1371/journal.pbio.1000475.

Danovi, D; Cremona, CA; Machado-da-Silva, G; Basu, S; Noon, LA; Parrinello, S; Lloyd, AC; (2010) A Genetic Screen for Anchorage-Independent Proliferation in Mammalian Cells Identifies a Membrane-Bound Neuregulin. PLOS ONE , 5 (7) , Article e11774. 10.1371/journal.pone.0011774. Green open access
file

Danovi, D; Falk, A; Humphreys, P; Vickers, R; Tinsley, J; Smith, AG; Pollard, SM; (2010) Imaging-based chemical screens using normal and glioma-derived neural stem cells. BIOCHEM SOC T , 38 1067 - 1071. 10.1042/BST0381067.

Dasgupta, Y; Virgili, A; Koptyra, M; Nacheva, EP; Skorski, T; (2010) Sensitivity to Imatinib In BCR ABL1 Positive Chronic Myeloid Leukemia Cells Depends on the Presence of Normal ABL1. In: BLOOD. (pp. 1394 - 1394). AMER SOC HEMATOLOGY

Davis, OSP; Butcher, LM; Docherty, SJ; Meaburn, EL; Curtis, CJC; Simpson, MA; Schalkwyk, LC; (2010) A Three-Stage Genome-Wide Association Study of General Cognitive Ability: Hunting the Small Effects. BEHAVIOR GENETICS , 40 (6) pp. 759-767. 10.1007/s10519-010-9350-4.

Della Peruta, M; Giagulli, C; Laudanna, C; Scarpa, A; Sorio, C; (2010) RHOA and PRKCZ control different aspects of cell motility in pancreatic cancer metastatic clones. MOL CANCER , 9 , Article 61. 10.1186/1476-4598-9-61. Gold open access

Della Peruta, M; Martinelli, G; Moratti, E; Pintani, D; Vezzalini, M; Mafficini, A; Grafone, T; (2010) Protein tyrosine phosphatase receptor type {gamma} is a functional tumor suppressor gene specifically downregulated in chronic myeloid leukemia. Cancer Res , 70 (21) pp. 8896-8906. 10.1158/0008-5472.CAN-10-0258.

Dhami, P; Bruce, AW; Jim, JH; Dillon, SC; Hall, A; Cooper, JL; Bonhoure, N; (2010) Genomic Approaches Uncover Increasing Complexities in the Regulatory Landscape at the Human SCL (TAL1) Locus. PLOS ONE , 5 (2) , Article e9059. 10.1371/journal.pone.0009059. Green open access
file

Dhami, P; Saffrey, P; Bruce, AW; Dillon, SC; Chiang, K; Bonhoure, N; Koch, CM; (2010) Complex Exon-Intron Marking by Histone Modifications Is Not Determined Solely by Nucleosome Distribution. PLOS ONE , 5 (8) , Article e12339. 10.1371/journal.pone.0012339. Green open access
file

Di Leva, G; Gasparini, P; Piovan, C; Ngankeu, A; Garofalo, M; Taccioli, C; Iorio, MV; (2010) MicroRNA Cluster 221-222 and Estrogen Receptor alpha Interactions in Breast Cancer. J NATL CANCER I , 102 (10) 706 - 721. 10.1093/jnci/djq102.

Dick, J; Begent, RH; Meyer, T; (2010) Sarcoidosis and testicular cancer: A case series and literature review. UROL ONCOL-SEMIN ORI , 28 (4) 350 - 354. 10.1016/j.urolonc.2008.09.029.

Dudderidge, TJ; Kelly, JD; Wollenschlaeger, A; Okoturo, O; Prevost, T; Robson, W; Leung, HY; (2010) Diagnosis of prostate cancer by detection of minichromosome maintenance 5 protein in urine sediments. BRIT J CANCER , 103 (5) 701 - 707. 10.1038/sj.bjc.6605785.

Duhamel, L; Damato, S; Halai, D; Shalaby, A; Ye, H; Idowu, B; Eskandarpour, M; (2010) Reduced Expression of the Tumour Suppressor Gene LKB1 in a Subset of Osteosarcomas. In: JOURNAL OF PATHOLOGY. (pp. S19 - S19). JOHN WILEY & SONS LTD

Dunn, JM; Jiao, Y; Austwick, M; Mosse, CA; Oukrif, D; Thorpe, S; Novelli, MR; (2010) ELASTIC SCATTERING SPECTROSCOPY IS HIGHLY ACCURATE FOR THE DETECTION OF HIGH-GRADE DYSPLASIA AND DNA PLOIDY ARISING IN BARRETT'S OESOPHAGUS USING A RED ENHANCED SPECTROMETER. In: GUT. (pp. A115 - A116). B M J PUBLISHING GROUP

Dunn, JM; Mackenzie, GD; Oukrif, D; Mosse, CA; Banks, MR; Thorpe, S; Sasieni, P; (2010) Image cytometry accurately detects DNA ploidy abnormalities and predicts late relapse to high-grade dysplasia and adenocarcinoma in Barrett's oesophagus following photodynamic therapy. BRIT J CANCER , 102 (11) 1608 - 1617. 10.1038/sj.bjc.6605688.

das Neves, RP; Jones, NS; Andreu, L; Gupta, R; Enver, T; Iborra, FJ; (2010) Connecting Variability in Global Transcription Rate to Mitochondrial Variability. PLOS BIOL , 8 (12) , Article e1000560. 10.1371/journal.pbio.1000560. Green open access
file

de Arenaza, DP; Pepper, J; Lees, B; Rubinstein, F; Nugara, F; Roughton, M; Jasinski, M; (2010) Preoperative 6-minute walk test adds prognostic information to Euroscore in patients undergoing aortic valve replacement. HEART , 96 (2) 113 - 117. 10.1136/hrt.2008.161174.

de Beaucoudrey, L; Samarina, A; Bustamante, J; Cobat, A; Boisson-Dupuis, S; Feinberg, J; Al-Muhsen, S; (2010) Revisiting human IL-12Rβ1 deficiency: a survey of 141 patients from 30 countries. Medicine (Baltimore) , 89 (6) pp. 381-402. 10.1097/MD.0b013e3181fdd832.

de Pagter, PJ; Virgili, A; Nacheva, E; van Baarle, D; Schuurman, R; Boelens, JJ; (2010) Chromosomally integrated human herpesvirus 6: transmission via cord blood-derived unrelated hematopoietic stem cell transplantation. Biol Blood Marrow Transplant , 16 (1) pp. 130-132. 10.1016/j.bbmt.2009.05.009.

E

Ernst, T; Lin, F; White, HE; La Rosee, P; Lion, T; Mitterbauer-Hohendanner, G; Vandenberghe, P; (2010) Harmonized Testing for BCR-ABL Kinase Domain Mutations In CML: Results of a Survey and First Control Round within 28 National Reference Laboratories In Europe. In: (Proceedings) 52nd Annual Meeting of the American-Society-of-Hematology (ASH). (pp. pp. 392-393). AMER SOC HEMATOLOGY

Evangeli, M; Mughal, K; Porter, JB; (2010) WHICH PSYCHOSOCIAL FACTORS ARE RELATED TO CHELATION ADHERENCE IN THALASSEMIA? A SYSTEMATIC REVIEW. HEMOGLOBIN , 34 (3) 305 - 321. 10.3109/03630269.2010.485080.

Evans, P; Kayyali, R; Hider, RC; Eccleston, J; Porter, JB; (2010) Mechanisms for the shuttling of plasma non-transferrin-bound iron (NTBI) onto deferoxamine by deferiprone. TRANSL RES , 156 (2) 55 - 67. 10.1016/j.trsl.2010.05.002.

Evans, PJ; Kayyali, R; Hider, RC; Davis, BA; Eccleston, J; Porter, JB; (2010) Mechanisms for the shuttling of plasma non-transferrin-bound iron (NTBI) onto deferoxamine by deferiprone. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 11 - 11). WILEY-BLACKWELL PUBLISHING, INC

F

Fenton, TR; Gwalter, J; Cramer, R; Gout, IT; (2010) S6K1 is acetylated at lysine 516 in response to growth factor stimulation. BIOCHEM BIOPH RES CO , 398 (3) 400 - 405. 10.1016/j.bbrc.2010.06.081.

Fenton, TR; Gwalter, J; Ericsson, J; Gout, IT; (2010) Histone acetyltransferases interact with and acetylate p70 ribosomal S6 kinases in vitro and in vivo. INT J BIOCHEM CELL B , 42 (2) 359 - 366. 10.1016/j.biocel.2009.11.022.

Ferrer, IR; Wagener, ME; Robertson, JM; Turner, AP; Araki, K; Ahmed, R; Kirk, AD; (2010) Cutting edge: Rapamycin augments pathogen-specific but not graft-reactive CD8+ T cell responses. J Immunol , 185 (4) pp. 2004-2008. 10.4049/jimmunol.1001176.

Fielding, AK; (2010) How I treat Philadelphia chromosome-positive acute lymphoblastic leukemia. BLOOD , 116 (18) 3409 - 3417. 10.1182/blood-2010-01-242750.

Figueroa Tentori, D.; (2010) Third party approach using cord blood Tregs in allo-transplantation. Doctoral thesis, UCL (University College London). Green open access
file

Fischer, U; Leidinger, P; Keller, A; Folarin, A; Keller, R; Graf, N; Lenhof, HP; (2010) Amplicons on chromosome 12q13-21 in glioblastoma recurrences. INT J CANCER , 126 (11) 2594 - 2602. 10.1002/ijc.24971.

Fish, R; Pinney, J; Jain, P; Addison, C; Jones, C; Jayawardene, S; Booth, J; (2010) The Incidence of Major Hemorrhagic Complications After Renal Biopsies in Patients with Monoclonal Gammopathies. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY , 5 (11) pp. 1977-1980.

Flanagan, AM; Delaney, D; O'Donnell, P; (2010) Benefits of molecular pathology in the diagnosis of musculoskeletal disease. SKELETAL RADIOL , 39 (3) 213 - 224. 10.1007/s00256-009-0758-y.

Flanagan, JM; Cocciardi, S; Waddell, N; Johnstone, CN; Marsh, A; Henderson, S; Simpson, P; (2010) DNA Methylome of Familial Breast Cancer Identifies Distinct Profiles Defined by Mutation Status. AM J HUM GENET , 86 (3) 420 - 433. 10.1016/j.ajhg.2010.02.008.

Flanagan, JM; Kugler, S; Waddell, N; Johnstone, CN; Marsh, A; Henderson, S; Simpson, P; (2010) DNA methylome of familial breast cancer identifies distinct profiles defined by mutation status. BREAST CANCER RESEARCH , 12 , Article O4. 10.1186/bcr2495.

Flicek, P; Aken, BL; Ballester, B; Beal, K; Bragin, E; Brent, S; Chen, Y; (2010) Ensembl's 10th year. Nucleic Acids Res , 38 (Database) D557-D562. 10.1093/nar/gkp972.

Flutter, B; Edwards, N; Fallah-Arani, F; Henderson, S; Chai, JG; Sivakumaran, S; Ghorashian, S; (2010) Nonhematopoietic antigen blocks memory programming of alloreactive CD8(+) T cells and drives their eventual exhaustion in mouse models of bone marrow transplantation. J CLIN INVEST , 120 (11) 3855 - 3868. 10.1172/JCI41446.

Flutter, BR; Fallah-Arani, F; Sivakumaran, S; Bennett, CL; Ghorashian, S; Freeman, G; Sykes, M; (2010) Failure to imprint donor CD8 memory and exhaustion may explain loss of GVT responses following donor leukocyte infusions. In: BONE MARROW TRANSPLANTATION. (pp. S16 - S16). NATURE PUBLISHING GROUP

Folarin, AA; Konerding, MA; Timonen, J; Nagl, S; Pedley, RB; (2010) Three-dimensional analysis of tumour vascular corrosion casts using stereoimaging and micro-computed tomography. MICROVASC RES , 80 (1) 89 - 98. 10.1016/j.mvr.2010.03.007.

Forster, M; Enting, D; Nicholson, AG; O'Brien, M; Popat, S; (2010) The combination of Young's syndrome and small cell lung cancer-A spiky connection? Lung Cancer , 67 (3) pp. 372-375. 10.1016/j.lungcan.2009.10.011.

Forster, MD; Saijo, N; Seymour, L; Calvert, H; (2010) Performing Phase I Clinical Trials of Anticancer Agents: Perspectives from within the European Union and Japan. CLIN CANCER RES , 16 (6) 1737 - 1744. 10.1158/1078-0432.CCR-09-2228.

Foukas, LC; Berenjeno, IM; Gray, A; Khwaja, A; Vanhaesebroeck, B; (2010) Activity of any class IA PI3K isoform can sustain cell proliferation and survival. P NATL ACAD SCI USA , 107 (25) 11381 - 11386. 10.1073/pnas.0906461107.

Franks, A; Tronrud, C; Kiakos, K; Kluza, J; Munde, M; Brown, T; Mackay, H; (2010) Targeting the ICB2 site of the topoisomerase II alpha promoter with a formamido-pyrrole-imidazole-pyrrole H-pin polyamide. BIOORGAN MED CHEM , 18 (15) 5553 - 5561. 10.1016/j.bmc.2010.06.041.

Freeman, S; Hills, R; Virgo, P; Couzens, S; Lowdell, MW; McNamara, CJ; White, P; (2010) Detection of Immunophenotypic Residual Disease After Induction Therapy Is An Independent Prognostic Factor for Duration of Remission In Older AML Patients Treated Intensively. In: BLOOD. (pp. 1118 - 1119). AMER SOC HEMATOLOGY

G

Georgiadis, A; Tschernutter, M; Bainbridge, JWB; Robbie, SJ; McIntosh, J; Nathwani, AC; Smith, AJ; (2010) AAV-mediated knockdown of Peripherin-2 in vivo using miRNA-based hairpins. GENE THER , 17 (4) 486 - 493. 10.1038/gt.2009.162.

Germani, G; Burroughs, AK; Dhillon, AP; (2010) The relationship between liver disease stage and liver fibrosis: a tangled web. HISTOPATHOLOGY , 57 (6) 773 - 784. 10.1111/j.1365-2559.2010.03609.x.

Germani, G; Pleguezuelo, M; Gurusamy, K; Meyer, T; Isgro, G; Burroughs, AK; (2010) Clinical outcomes of radiofrequency ablation, percutaneous alcohol and acetic acid injection for hepatocelullar carcinoma: A meta-analysis. J HEPATOL , 52 (3) 380 - 388.

Gerrard, G; Hill, S; Bazeos, A; Khorashad, J; De Lavallade, H; Apperley, J; Foroni, L; (2010) AURORA KINASE EXPRESSION IN CHRONIC MYELOID LEUKAEMIA: POTENTIAL MARKERS OF DISEASE PROGRESSION. In: (Proceedings) 15th Annual Meeting of the European-Hematology-Association. (pp. p. 334). FERRATA STORTI FOUNDATION

Gerrard, G; Hill, S; Khorashad, J; Bazeos, A; Apperley, J; Foroni, L; (2010) THE TUMOUR SUPPRESSOR PTEN: DIFFERENTIAL EXPRESSION PATTERNS IN CHRONIC MYELOID LEUKAEMIA AND THE ROLE OF PROMOTER METHYLATION. In: (Proceedings) 15th Annual Meeting of the European-Hematology-Association. (pp. p. 52). FERRATA STORTI FOUNDATION

Giampieri, S; Pinner, S; Sahai, E; (2010) Intravital Imaging Illuminates Transforming Growth Factor beta Signaling Switches during Metastasis. CANCER RESEARCH , 70 (9) pp. 3435-3439. 10.1158/0008-5472.CAN-10-0466.

Gillmore, R; Laurence, V; Raouf, S; Tobias, J; Blackman, G; Meyer, T; Goodchild, K; (2010) Chemoradiotherapy with or without Induction Chemotherapy for Locally Advanced Pancreatic Cancer: a UK Multi-institutional Experience. CLIN ONCOL-UK , 22 (7) 564 - 569. 10.1016/j.clon.2010.05.007.

Gisselbrecht, C; Glass, B; Mounier, N; Gill, DS; Linch, DC; Trneny, M; Bosly, A; (2010) Salvage Regimens With Autologous Transplantation for Relapsed Large B-Cell Lymphoma in the Rituximab Era. JOURNAL OF CLINICAL ONCOLOGY , 28 (27) 4184 - 4190. 10.1200/JCO.2010.28.1618.

Goldberg, AD; Banaszynski, LA; Noh, KM; Lewis, PW; Elsaesser, SJ; Stadler, S; Dewell, S; (2010) Distinct Factors Control Histone Variant H3.3 Localization at Specific Genomic Regions. CELL , 140 (5) 678 - 691. 10.1016/j.cell.2010.01.003.

Gomez, K; (2010) Textbook of Hemophilia. In: Lee, CA and Berntorp, EE and Hoots, WK, (eds.) Textbook of Hemophilia. (? - ?). Wiley-Blackwell

Gomez, K; (2010) Textbook of Hemophilia. In: Lee, CA and Berntorp, EE and Hoots, WK, (eds.) Textbook of Hemophilia. (? - ?). Wiley-Blackwell

Grant, H; Jiang, X; Stebbing, J; Foroni, L; Craddock, C; Griffiths, M; Clark, RE; (2010) Analysis of BCR-ABL1 tyrosine kinase domain mutational spectra in primitive chronic myeloid leukemia cells suggests a unique mutator phenotype. LEUKEMIA , 24 (10) pp. 1817-1821. 10.1038/leu.2010.179.

Green, CL; Evans, CM; Hills, RK; Burnett, AK; Linch, DC; Gale, RE; (2010) The prognostic significance of IDH1 mutations in younger adult patients with acute myeloid leukaemia is dependent on FLT3/ITD status. BRITISH JOURNAL OF HAEMATOLOGY , 149 17 - 17.

Green, CL; Evans, CM; Hills, RK; Burnett, AK; Linch, DC; Gale, RE; (2010) The prognostic significance of IDH1 mutations in younger adult patients with acute myeloid leukemia is dependent on FLT3/ITD status. BLOOD , 116 (15) 2779 - 2782. 10.1182/blood-2010-02-270926.

Green, L; Lawrie, AS; Patel, S; Hossain, F; Chitolie, A; Mackie, IJ; Haddad, FS; (2010) The impact of elective knee/hip replacement surgery and thromboprophylaxis with rivaroxaban or dalteparin on thrombin generation. BRIT J HAEMATOL , 151 (5) 469 - 476. 10.1111/j.1365-2141.2010.08433.x.

Green, L; Lawrie, AS; Patel, S; Hossain, FS; Mackie, IJ; Haddad, F; Machin, SJ; (2010) Lower doses of prothrombin complex concentrate achieve emergency reversal of warfarin. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 13 - 13). WILEY-BLACKWELL PUBLISHING, INC

Green, L; Lawrie, AS; Patel, S; Hossain, FS; Mackie, IJ; Haddad, F; Machin, SJ; (2010) A comparison of rivaroxaban and fragmin prophylaxis after high risk orthopaedic surgery on thrombin generation test. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 13 - 13). WILEY-BLACKWELL PUBLISHING, INC

Green, L; Machin, SJ; (2010) Managing anticoagulated patients during neuraxial anaesthesia. BRIT J HAEMATOL , 149 (2) 195 - 208. 10.1111/j.1365-2141.2010.08094.x.

Guerra-Assunção, JA; Enright, AJ; (2010) MapMi: automated mapping of microRNA loci. BMC Bioinformatics , 11 133-. 10.1186/1471-2105-11-133.

H

Hadjur, S; Williams, L; Mira, H; Fisher, AG; Merkenschlager, M; (2010) Cohesins Contribute to Long-Range Chromosomal cis-Interactions. In: AMERICAN JOURNAL OF MEDICAL GENETICS PART A. (pp. 1634 - 1634). WILEY-LISS

Hall, AR; Germani, G; Burroughs, AK; Dhillon, AP; (2010) COLLAGEN QUANTIFICATION BY DIGITAL IMAGE ANALYSIS IN DIFFERENT AETIOLOGIES AND RIGHT VS LEFT LOBES IN EXPLANTED CIRRHOTIC LIVERS. In: HEPATOLOGY. (pp. 1126A - 1126A). WILEY-BLACKWELL

Hampel, SM; Sidibe, A; Gunaratnam, M; Riou, JF; Neidle, S; (2010) Tetrasubstituted naphthalene diimide ligands with selectivity for telomeric G-quadruplexes and cancer cells. Bioorg Med Chem Lett , 20 (22) pp. 6459-6463. 10.1016/j.bmcl.2010.09.066.

Hansen, A; Henderson, S; Lagos, D; Nikitenko, L; Coulter, E; Roberts, S; Gratrix, F; (2010) KSHV-encoded miRNAs target MAF to induce endothelial cell reprogramming. GENE DEV , 24 (2) 195 - 205. 10.1101/gad.553410.

Hansen, A.; (2010) Kaposi sarcoma herpesvirus microRNA function in lymphatic endothelial cells. Doctoral thesis, UCL (University College London). Green open access
file

Hartley, JA; Hamaguchi, A; Coffils, M; Martin, CRH; Suggitt, M; Chen, ZZ; Gregson, SJ; (2010) SG2285, a Novel C2-Aryl-Substituted Pyrrolobenzodiazepine Dimer Prodrug That Cross-links DNA and Exerts Highly Potent Antitumor Activity. CANCER RES , 70 (17) 6849 - 6858. 10.1158/0008-5472.CAN-10-0790.

Hergovich, A; Hemmings, BA; (2010) TAZ-Mediated Crosstalk between Wnt and Hippo Signaling. DEV CELL , 18 (4) 508 - 509. 10.1016/j.devcel.2010.04.003.

Hirani, V; Tabassum, F; Aresu, M; Mindell, J; (2010) Development of New Demi-Span Equations from a Nationally Representative Sample of Adults to Estimate Maximal Adult Height. J NUTR , 140 (8) 1475 - 1480. 10.3945/jn.109.118430.

Howard-Reeves, D; Chanalaris, A; Grace, C; Gale, R; Linch, D; Nacheva, E; (2010) THE TRANSLOCATION T(8;21) IN AML IS TRULY BALANCED AS SHOWN BY ARRAY CGH AT 2.5KB RESOLUTION. In: (Proceedings) 15th Annual Meeting of the European-Hematology-Association. (pp. p. 676). FERRATA STORTI FOUNDATION Gold open access

Hua, J; Spee, C; Kase, S; Rennel, ES; Magnussen, AL; Qiu, Y; Varey, A; (2010) Recombinant Human VEGF(165)b Inhibits Experimental Choroidal Neovascularization. INVEST OPHTH VIS SCI , 51 (8) 4282 - 4288. 10.1167/iovs.09-4360.

I

Illingworth, C; Pirmadjid, N; Serhal, P; Howe, K; FitzHarris, G; (2010) MCAK regulates chromosome alignment but is not necessary for preventing aneuploidy in mouse oocyte meiosis I. DEVELOPMENT , 137 (13) 2133 - 2138. 10.1242/dev.048306.

Isgro, G; Andreana, L; Garcovich, M; Luong, TV; Hall, AR; Goossens, N; Tsochatzis, E; (2010) HISTOLOGICAL LIVER COLLAGEN PROPORTIONATE AREA PREDICTS DECOMPENSATION IN PATIENTS WITH. LIVER CIRRHOSIS OF DIFFERENT ETIOLOGIES. In: HEPATOLOGY. (pp. 920A - 920A). WILEY-BLACKWELL

Isgro, G; Calvarusou, V; Manousou, P; Luong, TV; Andreana, L; Maimone, S; Makalanda, L; (2010) WHICH CORRELATION AMONG HISTOLOGICAL ASSESSMENT OF FIBROSIS, NON-INVASIVE MARKERS AND PORTAL HYPERTENSION IN HCV TRANSPLANTED PATIENTS? In: JOURNAL OF HEPATOLOGY. (pp. S192 - S193). ELSEVIER SCIENCE BV

Isgro, G; Garcovich, M; Luong, TV; Andreana, L; Maimone, S; Manousou, P; Patch, DW; (2010) COLLAGEN PROPORTIONATE AREA: THE MOST APPROPRIATE INDEX TO CORRELATE WITH TRANSIENT ELASTOGRAPHY. In: HEPATOLOGY. (pp. 411A - 411A). WILEY-BLACKWELL

Ito, T; Kwon, HY; Zimdahl, B; Congdon, KL; Blum, J; Lento, WE; Zhao, C; (2010) Regulation of myeloid leukaemia by the cell-fate determinant Musashi. NATURE , 466 (7307) 765-U13. 10.1038/nature09171.

Ito, T; Kwon, HY; Zimdahl, B; Congdon, KL; Blum, J; Lento, WE; Zhao, C; (2010) Regulation of myeloid leukemia by the cell fate determinant Musashi. DIFFERENTIATION , 80 S41-S41. 10.1016/j.diff.2010.09.079.

J

Jacques, TS; Swales, A; Brzozowski, MJ; Henriquez, NV; Linehan, JM; Mirzadeh, Z; Malley, CO; (2010) Combinations of genetic mutations in the adult neural stem cell compartment determine brain tumour phenotypes. EMBO J , 29 (1) 222 - 235. 10.1038/emboj.2009.327. Gold open access

Jiang, X; Grant, H; Stebbing, J; Foroni, L; Craddock, C; Griffiths, M; Clark, RE; (2010) Analysis of BCR-ABL1 Tyrosine Kinase Domain Mutations In Primitive Chronic Myeloid Leukemia Cells Identifies a Unique Mutator Phenotype. In: (Proceedings) 52nd Annual Meeting of the American-Society-of-Hematology (ASH). (pp. pp. 1390-1391). AMER SOC HEMATOLOGY

Johnson, G; Hatfield, A; Webster, G; Groves, C; Rodriguez-Justo, M; (2010) A diagnosis of an intraluminal carcinoid tumor of the bile duct by using cholangioscopy. Gastrointest Endosc , 71 (3) pp. 622-623. 10.1016/j.gie.2009.10.014.

Joseph, L; Hing, SN; Presneau, N; O'Donnell, P; Diss, T; Idowu, BD; Joseph, S; (2010) Familial tumoral calcinosis and hyperostosis-hyperphosphataemia syndrome are different manifestations of the same disease: novel missense mutations in GALNT3. SKELETAL RADIOL , 39 (1) 63 - 68. 10.1007/s00256-009-0808-5.

Juul, N; Szallasi, Z; Eklund, AC; Li, Q; Burrell, RA; Gerlinger, M; Valero, V; (2010) Assessment of an RNA interference screen-derived mitotic and ceramide pathway metagene as a predictor of response to neoadjuvant paclitaxel for primary triple-negative breast cancer: a retrospective analysis of five clinical trials. Lancet Oncol , 11 (4) pp. 358-365. 10.1016/S1470-2045(10)70018-8.

K

Kakourou, G; Dhanjal, S; Mamas, T; Serhal, P; Delhanty, JD; SenGupta, SB; (2010) Modification of the triplet repeat primed polymerase chain reaction method for detection of the CTG repeat expansion in myotonic dystrophy type 1: application in preimplantation genetic diagnosis. FERTIL STERIL , 94 (5) 1674 - 1679. 10.1016/j.fertnstert.2009.10.050.

Kallinikou, K; Anjos-Afonso, F; Linch, D; Bonnet, D; Yong, K; (2010) ENGRAFTMENT DEFECT OF CYTOKINE-ACTIVATED HUMAN CD34+CELLS IS RELATED TO REDUCED ADHESION TO BONE MARROW (BM) ELEMENTS. In: EXPERIMENTAL HEMATOLOGY. (pp. S18 - S18). ELSEVIER SCIENCE INC

Kanhere, A; Viiri, K; Araujo, CC; Rasaiyaah, J; Bouwman, RD; Whyte, WA; Pereira, CF; (2010) Short RNAs Are Transcribed from Repressed Polycomb Target Genes and Interact with Polycomb Repressive Complex-2. MOL CELL , 38 (5) 675 - 688. 10.1016/j.molcel.2010.03.019.

Kapur, A; Hall, RJ; Malik, IS; Qureshi, AC; Butts, J; de Belder, M; Baumbach, A; (2010) Randomized Comparison of Percutaneous Coronary Intervention With Coronary Artery Bypass Grafting in Diabetic Patients 1-Year Results of the CARDia (Coronary Artery Revascularization in Diabetes) Trial. J AM COLL CARDIOL , 55 (5) 432 - 440. 10.1016/j.jacc.2009.10.014.

Karp, DR; Marthandan, N; Marsh, SGE; Ahn, C; Arnett, FC; DeLuca, DS; Diehl, AD; (2010) Novel sequence feature variant type analysis of the HLA genetic association in systemic sclerosis. HUMAN MOLECULAR GENETICS , 19 (4) pp. 707-719. 10.1093/hmg/ddp521.

Kersey, PJ; Lawson, D; Birney, E; Derwent, PS; Haimel, M; Herrero, J; Keenan, S; (2010) Ensembl Genomes: extending Ensembl across the taxonomic space. Nucleic Acids Res , 38 (Database) D563-D569. 10.1093/nar/gkp871.

Khorashad, J; Hu, M; Hopmeier, D; Daghistani, M; May, P; Gerrard, G; Marin, D; (2010) NAMPT, A MEDIATOR OF NORMAL GRANULOCYTIC DIFFERENTIATION, IS DOWN-REGULATED IN CHRONIC MYELOID LEUKAEMIA VIA CHROMATIN MODIFICATION. In: (Proceedings) 15th Annual Meeting of the European-Hematology-Association. (pp. pp. 49-50). FERRATA STORTI FOUNDATION

Kiakos, K; Hartley, JM; Hartley, JA; (2010) Measurement of DNA interstrand crosslinking in naked DNA using gel-based methods. Methods Mol Biol , 613 pp. 283-302. 10.1007/978-1-60327-418-0_18.

Knight, A; Madrigal, AJ; Grace, S; Sivakumaran, J; Kottaridis, P; Mackinnon, S; Travers, PJ; (2010) The role of V delta 2-negative gamma delta T cells during cytomegalovirus reactivation in recipients of allogeneic stem cell transplantation. BLOOD , 116 (12) 2164 - 2172. 10.1182/blood-2010-01-255166.

Kocjan, G; Chandra, A; Cross, P; Giles, T; Johnson, S; Poller, D; Stephenson, T; (2010) CONFIRMATION OF THE REPRODUCIBILITY OF THYROID FNA USING THE 2009 UK ROYAL COLLEGE OF PATHOLOGISTS 'THY' REPORTING NOMENCLATURE. ACTA CYTOL , 54 (3) 403 - 403.

Kocjan, G; Cochand-Priollet, B; de Agustin, PP; Bourgain, C; Chandra, A; Daneshbod, Y; Deery, A; (2010) Diagnostic terminology for reporting thyroid fine needle aspiration cytology: European Federation of Cytology Societies thyroid working party symposium, Lisbon 2009. CYTOPATHOLOGY , 21 (2) 86 - 92. 10.1111/j.1365-2303.2010.00751.x.

Kocjan, G; Ramsay, A; Young, M; Beale, T; Cassoni, A; Kurzawinsky, T; (2010) Spindle cell lesion of thyroid: a potential pitfall in FNAC diagnosis. CYTOPATHOLOGY , 21 (2) 123 - 126. 10.1111/j.1365-2303.2009.00705.x.

Kohler, RS; Schmitz, D; Cornils, H; Hemmings, BA; Hergovich, A; (2010) Differential NDR/LATS Interactions with the Human MOB Family Reveal a Negative Role for Human MOB2 in the Regulation of Human NDR Kinases. MOL CELL BIOL , 30 (18) 4507 - 4520. 10.1128/MCB.00150-10.

Kuehn, HS; Rådinger, M; Brown, JM; Ali, K; Vanhaesebroeck, B; Beaven, MA; Metcalfe, DD; (2010) Btk-dependent Rac activation and actin rearrangement following FcepsilonRI aggregation promotes enhanced chemotactic responses of mast cells. J Cell Sci , 123 (Pt 15) pp. 2576-2585. 10.1242/jcs.071043.

L

Lafont, E; Milhas, D; Carpentier, S; Garcia, V; Jin, ZX; Umehara, H; Okazaki, T; (2010) Caspase-mediated inhibition of sphingomyelin synthesis is involved in FasL-triggered cell death. Cell Death Differ , 17 (4) pp. 642-654. 10.1038/cdd.2009.130.

Lafont, E; Milhas, D; Teissié, J; Therville, N; Andrieu-Abadie, N; Levade, T; Benoist, H; (2010) Caspase-10-dependent cell death in Fas/CD95 signalling is not abrogated by caspase inhibitor zVAD-fmk. PLoS One , 5 (10) , Article e13638. 10.1371/journal.pone.0013638. Green open access
file

Lagos, D; Pollara, G; Henderson, S; Gratrix, F; Fabani, M; Milne, RSB; Gotch, F; (2010) miR-132 regulates antiviral innate immunity through suppression of the p300 transcriptional co-activator. NAT CELL BIOL , 12 (5) 513 - U232. 10.1038/ncb2054.

Lambert, JR; Bomanji, JB; Peggs, KS; Thomson, KJ; Chakraverty, RK; Fielding, AK; Kottaridis, PD; (2010) Prognostic role of PET scanning before and after reduced-intensity allogeneic stem cell transplantation for lymphoma. BLOOD , 115 (14) 2763 - 2768. 10.1182/blood-2009-11-255182.

Landeira, D; Sauer, S; Poot, R; Dvorkina, M; Mazzarella, L; Jorgensen, HF; Pereira, CF; (2010) Jarid2 is a PRC2 component in embryonic stem cells required for multi-lineage differentiation and recruitment of PRC1 and RNA Polymerase II to developmental regulators. NAT CELL BIOL , 12 (6) 618 - U214. 10.1038/ncb2065.

Landmeier, S; Altvater, B; Pscherer, S; Meltzer, J; Sebire, N; Pule, M; Vera, J; (2010) Cytotoxic T cells transduced with chimeric anti-CD19 receptors prevent engraftment of primary lymphoblastic leukemia in vivo. LEUKEMIA , 24 (5) 1080 - 1084. 10.1038/leu.2010.38.

Lawrenson, K; Grun, B; Benjamin, E; Jacobs, IJ; Dafou, D; Gayther, SA; (2010) Senescent Fibroblasts Promote Neoplastic Transformation of Partially Transformed Ovarian Epithelial Cells in a Three-dimensional Model of Early Stage Ovarian Cancer. NEOPLASIA , 12 (4) 317 - U37. 10.1593/neo.91948. Gold open access

Lawrie, AS; Green, L; Canciani, MT; Mackie, IJ; Machin, SJ; Peyvandi, F; Scully, MA; (2010) The haemostatic impact of prion reduction in solvent detergent treated plasma. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 64 - 65). WILEY-BLACKWELL PUBLISHING, INC

Lawrie, AS; Green, L; Canciani, MT; Mackie, IJ; Peyvandi, F; Scully, MA; Machin, SJ; (2010) THE EFFECT OF PRION REDUCTION IN SOLVENT DETERGENT TREATED PLASMA ON HAEMOSTATIC VARIABLES. VOX SANG , 99 235 - 235.

Lawrie, AS; Green, L; Canciani, MT; Mackie, IJ; Peyvandi, F; Scully, MA; Machin, SJ; (2010) The effect of prion reduction in solvent/detergent-treated plasma on haemostatic variables. VOX SANG , 99 (3) 232 - 238. 10.1111/j.1423-0410.2010.01346.x.

Lawrie, AS; Green, L; Canciani, MT; Mackie, IJ; Peyvandi, F; Scully, MA; Machin, SJ; (2010) The effect of prion reduction in solvent/detergent-treated plasma on haemostatic variables. Vox Sang , 99 (3) pp. 232-238. 10.1111/j.1423-0410.2010.01346.x.

Lawrie, AS; Green, L; Mackie, IJ; Liesner, R; Machin, SJ; Peyvandi, F; (2010) Factor XIII - an under diagnosed deficiency - are we using the right assays? J THROMB HAEMOST , 8 (11) 2478 - 2482. 10.1111/j.1538-7836.2010.04028.x.

Lawrie, AS; Mackie, IJ; Machin, SJ; Peyvandi, F; (2010) Acquired factor XIII deficiency - an under investigated disorder. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 1 - 1). WILEY-BLACKWELL PUBLISHING, INC

Lawrie, AS; Mackie, IJ; Peyvandi, F; Machin, SJ; Peyvandi, F; Scully, MA; (2010) Evaluation of an automated platelet-based assay of von Willebrand ristocetin cofactor activity. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 33 - 33). WILEY-BLACKWELL PUBLISHING, INC

Lawson, ARJ; Tatevossian, RG; Phipps, KP; Picker, SR; Michalski, A; Sheer, D; Jacques, TS; (2010) RAF gene fusions are specific to pilocytic astrocytoma in a broad paediatric brain tumour cohort. ACTA NEUROPATHOL , 120 (2) 271 - 273. 10.1007/s00401-010-0693-y.

Lechner, M; Boshoff, C; Beck, S; (2010) Cancer epigenome. Adv Genet , 70 pp. 247-276. 10.1016/B978-0-12-380866-0.60009-5.

Lechner, M; Boshoff, C; Beck, S; (2010) Cancer Epigenome. EPIGENETICS AND CANCER, PT A , 70 pp. 247-276. 10.1016/S0065-2660(10)70009-2.

Ledermann, JA; Gabra, H; Jayson, GC; Spanswick, VJ; Rustin, GJS; Jitlal, M; James, LE; (2010) Inhibition of Carboplatin-Induced DNA Interstrand Cross-link Repair by Gemcitabine in Patients Receiving these Drugs for Platinum-Resistant Ovarian Cancer. CLIN CANCER RES , 16 (19) 4899 - 4905. 10.1158/1078-0432.CCR-10-0832.

Ledermann, JA; Kristeleit, RS; (2010) Optimal treatment for relapsing ovarian cancer. ANN ONCOL , 21 218 - 222. 10.1093/annonc/mdq377.

Ledermann, JA; Raja, FA; (2010) Targeted trials in ovarian cancer. GYNECOL ONCOL , 119 (1) 151 - 156. 10.1016/j.ygyno.2010.05.008.

Lee, JW; Yoon, SS; Shen, ZXA; Ganser, A; Hsu, HC; Habr, D; Domokos, G; (2010) Iron chelation therapy with deferasirox in patients with aplastic anemia: a subgroup analysis of 116 patients from the EPIC trial. BLOOD , 116 (14) 2448 - 2454. 10.1182/blood-2010-01-261289.

Lee, L; Ahmed, SO; Symeonidis, A; Linch, DC; Goldstone, A; Chakraverty, R; Mackinnon, S; (2010) Cardiac toxicity in patients over the age of 60 undergoing autologous stem cell transplantation for lymphoma. In: BONE MARROW TRANSPLANTATION. (pp. S101 - S101). NATURE PUBLISHING GROUP

Lee, SM; Edwards, SG; Chilton, DN; Ramsay, A; Miller, RF; (2010) Highly active antiretroviral therapy alone may be an effective treatment for HIV-associated multicentric Castleman's disease. HAEMATOL-HEMATOL J , 95 (11) 1979 - 1981. 10.3324/haematol.2010.027441. Gold open access

Li, N; Ye, M; Li, Y; Yan, Z; Butcher, LM; Sun, J; Han, X; (2010) Whole genome DNA methylation analysis based on high throughput sequencing technology. METHODS , 52 (3) pp. 203-212. 10.1016/j.ymeth.2010.04.009.

Li, Q; Eklund, AC; Juul, N; Haibe-Kains, B; Workman, CT; Richardson, AL; Szallasi, Z; (2010) Minimising immunohistochemical false negative ER classification using a complementary 23 gene expression signature of ER status. PLoS One , 5 (12) , Article e15031. 10.1371/journal.pone.0015031.

Li, YR; Zhu, JD; Tian, G; Li, N; Li, QB; Ye, MZ; Zheng, HC; (2010) The DNA Methylome of Human Peripheral Blood Mononuclear Cells. PLoS Biology , 8 (11) , Article e1000533. 10.1371/journal.pbio.1000533. Green open access
file

Lin, WR; Lim, SN; McDonald, SAC; Graham, T; Wright, VL; Peplow, CL; Humphries, A; (2010) The Histogenesis of Regenerative Nodules in Human Liver Cirrhosis. HEPATOLOGY , 51 (3) 1017 - 1026. 10.1002/hep.23483.

Linch, DC; Yung, L; Smith, P; Maclennan, K; Jack, A; Hancock, B; Cunningham, D; (2010) Final analysis of the UKLG LY02 trial comparing 6-8 cycles of CHOP with 3 cycles of CHOP followed by a BEAM autograft in patients < 65 years with poor prognosis histologically aggressive NHL. BRIT J HAEMATOL , 149 (2) 237 - 243. 10.1111/j.1365-2141.2010.08081.x.

Litte, AM; Marsh, SGE; Madrigal, JA; (2010) Histocompatibility. In: Hoffbrand, AV and Catovsky, D and Tuddenham, EGD and Green, AR, (eds.) Postgraduate Haematology. (pp. 710-721). Blackwell Publishing: Oxford, UK.

Lohi, O; Arola, M; Lautenschlager, I; Nacheva, EP; Vettenranta, K; (2010) A High Circulating Copy Number of HHV-6 Due to Chromosomal Integration in a Child With Acute Lymphoblastic Leukemia. PEDIATR BLOOD CANCER , 55 (6) 1236 - 1238. 10.1002/pbc.22671.

Low, PC; Misaki, R; Schroder, K; Stanley, AC; Sweet, MJ; Teasdale, RD; Vanhaesebroeck, B; (2010) Phosphoinositide 3-kinase δ regulates membrane fission of Golgi carriers for selective cytokine secretion. J Cell Biol , 190 (6) pp. 1053-1065. 10.1083/jcb.201001028.

M

Magnussen, AL; Rennel, ES; Hua, J; Bevan, HS; Long, NB; Lehrling, C; Gammons, M; (2010) VEGF-A(165)b Is Cytoprotective and Antiangiogenic in the Retina. INVEST OPHTH VIS SCI , 51 (8) 4273 - 4281. 10.1167/iovs.09-4296.

Maiers, M; Bakker, JNA; Bochtler, W; Eberhard, H-P; Marsh, SGE; Mueller, C; Rist, H-G; (2010) Information technology and the role of WMDA in promoting standards for international exchange of hematopoietic stem cell donors and products. BONE MARROW TRANSPLANTATION , 45 (5) pp. 839-842. 10.1038/bmt.2010.29.

Manchado, E; Guillamot, M; de Carcer, G; Eguren, M; Trickey, M; Garcia-Higuera, I; Moreno, S; (2010) Targeting Mitotic Exit Leads to Tumor Regression In Vivo: Modulation by Cdk1, Mastl, and the PP2A/B55 alpha,delta Phosphatase. CANCER CELL , 18 (6) 641 - 654. 10.1016/j.ccr.2010.10.028.

Manousou, P; Arvaniti, V; Tsochatzis, E; Isgro, G; Jones, K; Shirling, G; Dhillon, AP; (2010) Primary Biliary Cirrhosis After Liver Transplantation: Influence of Immunosuppression and Human Leukocyte Antigen Locus Disparity. LIVER TRANSPLANT , 16 (1) 64 - 73. 10.1002/lt.21960.

Manousou, P; Burroughs, AK; Isgro, G; Calvaruso, V; Tsochatzis, E; Arvaniti, V; Thornburn, D; (2010) DIGITAL IMAGE ANALYSIS OF LIVER FIBROSIS USING COLLAGEN PROPORTIONATE AREA IS BETTER THAN ISHAK STAGE FOR DETERMINATION OF RAPID FIBROSIS PROGRESSION IN RECURRENT HCV DISEASE AFTER LIVER TRANSPLANTATION. In: HEPATOLOGY. (pp. 836A - 836A). WILEY-BLACKWELL

Manousou, P; Dhillon, A; Burroughs, AK; (2010) Reply: Outcome of Recurrent Hepatitis C Virus After Liver Transplantation in a Randomized Trial of Tacrolimus Monotherapy Versus Triple Therapy Reply. LIVER TRANSPLANT , 16 (5) 689 - 690. 10.1002/lt.22061.

Manousou, P; Samonakis, D; Cholongitas, E; Isgro, G; Calvaruso, V; Tsochatzis, E; Patch, DW; (2010) CPA MEASUREMENT AT ONE YEAR BIOPSY IS HIGHLY PREDICTIVE OF FUTURE CLINICAL DECOMPENSATION IN HCV POST-TRANSPLANT PATIENTS RANDOMIZED IN TACROLIMUS MONOTHERAPY VERSUS TRIPLE THERAPY (TACROLIMUS-BASED). In: JOURNAL OF HEPATOLOGY. (pp. S194 - S195). ELSEVIER SCIENCE BV

Marafioti, T; Paterson, JC; Ballabio, E; Chott, A; Natkunam, Y; Rodriguez-Justo, M; Plonquet, A; (2010) The inducible T-cell co-stimulator molecule is expressed on subsets of T cells and is a new marker of lymphomas of T follicular helper cell-derivation. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL , 95 (3) pp. 432-439. 10.3324/haematol.2009.010991.

Marsh, SGE; (2010) Nomenclature for factors of the HLA system, update April 2010. TISSUE ANTIGENS , 76 (6) pp. 501-508. 10.1111/j.1399-0039.2010.01551.x.

Marsh, SGE; (2010) Nomenclature for factors of the HLA system, update August 2009. TISSUE ANTIGENS , 75 (1) pp. 98-101. 10.1111/j.1399-0039.2009.01402.x.

Marsh, SGE; (2010) Nomenclature for factors of the HLA system, update December 2009. TISSUE ANTIGENS , 76 (1) pp. 81-85. 10.1111/j.1399-0039.2010.01462.x.

Marsh, SGE; (2010) Nomenclature for factors of the HLA system, update February 2010. TISSUE ANTIGENS , 76 (2) pp. 165-170. 10.1111/j.1399-0039.2010.01508.x.

Marsh, SGE; (2010) Nomenclature for factors of the HLA system, update January 2010. TISSUE ANTIGENS , 76 (2) pp. 161-164. 10.1111/j.1399-0039.2010.01507.x.

Marsh, SGE; (2010) Nomenclature for factors of the HLA system, update July 2009. TISSUE ANTIGENS , 75 (1) pp. 90-97. 10.1111/j.1399-0039.2009.01403.x.

Marsh, SGE; (2010) Nomenclature for factors of the HLA system, update June 2010. TISSUE ANTIGENS , 76 (6) pp. 514-518. 10.1111/j.1399-0039.2010.01553.x.

Marsh, SGE; (2010) Nomenclature for factors of the HLA system, update May 2010. TISSUE ANTIGENS , 76 (6) pp. 509-513. 10.1111/j.1399-0039.2010.01552.x.

Marsh, SGE; (2010) Nomenclature for factors of the HLA system, update November 2009. TISSUE ANTIGENS , 76 (1) pp. 76-80. 10.1111/j.1399-0039.2010.01452.x.

Marsh, SGE; (2010) Nomenclature for factors of the HLA system, update October 2009. TISSUE ANTIGENS , 75 (6) pp. 741-746. 10.1111/j.1399-0039.2010.01453.x.

Marsh, SGE; (2010) Nomenclature for factors of the HLA system, update September 2009. TISSUE ANTIGENS , 75 (2) pp. 189-196.

Marsh, SGE; Albert, ED; Bodmer, WF; Bontrop, RE; Dupont, B; Erlich, HA; Fernandez-Vina, M; (2010) Nomenclature for factors of the HLA system, 2010. TISSUE ANTIGENS , 75 (4) pp. 291-455. 10.1111/j.1399-0039.2010.01466.x.

Marsh, SGE; Albert, ED; Bodmer, WF; Bontrop, RE; Dupont, B; Erlich, HA; Fernandez-Vina, M; (2010) An update to HLA Nomenclature, 2010. BONE MARROW TRANSPLANTATION , 45 (5) pp. 846-848. 10.1038/bmt.2010.79.

Martin, V; Guillermet-Guibert, J; Chicanne, G; Cabou, C; Jandrot-Perrus, M; Plantavid, M; Vanhaesebroeck, B; (2010) Deletion of the p110beta isoform of phosphoinositide 3-kinase in platelets reveals its central role in Akt activation and thrombus formation in vitro and in vivo. Blood , 115 (10) pp. 2008-2013. 10.1182/blood-2009-04-217224.

Matthews, DR; Carlin, LM; Ofo, E; Barber, PR; Vojnovic, B; Irving, M; Ng, T; (2010) Time-lapse FRET microscopy using fluorescence anisotropy. J Microsc , 237 (1) pp. 51-62. 10.1111/j.1365-2818.2009.03301.x.

McBride, DJ; Orpana, AK; Sotiriou, C; Joensuu, H; Stephens, PJ; Mudie, LJ; Hamalainen, E; (2010) Use of Cancer-Specific Genomic Rearrangements to Quantify Disease Burden in Plasma from Patients with Solid Tumors. GENES CHROMOSOMES & CANCER , 49 (11) pp. 1062-1069. 10.1002/gcc.20815.

McDonald, V; Liesner, R; Grainger, J; Gattens, M; Machin, SJ; Scully, M; (2010) Acquired, noncongenital thrombotic thrombocytopenic purpura in children and adolescents: clinical management and the use of ADAMTS 13 assays. BLOOD COAGUL FIBRIN , 21 (3) 245 - 250. 10.1097/MBC.0b013e32833679cb.

McDonald, V; Mackie, IJ; Machin, SJ; Scully, MA; (2010) Anti-ADAMTS13 IgG antibody subclasses in thrombotic thrombocytopenic purpura and changes with rituximab therapy. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 5 - 5). WILEY-BLACKWELL PUBLISHING, INC

McDonald, V; Manns, K; Mackie, IJ; Machin, SJ; Scully, MA; (2010) Rituximab pharmacokinetics during the management of acute idiopathic thrombotic thrombocytopenic purpura. J THROMB HAEMOST , 8 (6) 1201 - 1208. 10.1111/j.1538-7836.2010.03818.x.

McGee, MC; Hamner, JB; Williams, RF; Rosati, SF; Sims, TL; Ng, CY; Gaber, MW; (2010) IMPROVED INTRATUMORAL OXYGENATION THROUGH VASCULAR NORMALIZATION INCREASES GLIOMA SENSITIVITY TO IONIZING RADIATION. INT J RADIAT ONCOL , 76 (5) 1537 - 1545. 10.1016/j.ijrobp.2009.12.010.

McKeen, HD; Byrne, C; Jithesh, PV; Donley, C; Valentine, A; Yakkundi, A; O'Rourke, M; (2010) FKBPL regulates estrogen receptor signaling and determines response to endocrine therapy. Cancer Res , 70 (3) pp. 1090-1100. 10.1158/0008-5472.CAN-09-2515.

Mead, AJ; Thomson, KJ; Morris, EC; Mohamedbhai, S; Denovan, S; Orti, G; Fielding, AK; (2010) HLA-mismatched unrelated donors are a viable alternate graft source for allogeneic transplantation following alemtuzumab-based reduced-intensity conditioning. BLOOD , 115 (25) 5147 - 5153. 10.1182/blood-2010-01-265413.

Mednick, L; Yu, SL; Trachtenberg, F; Xu, Y; Kleinert, DA; Giardina, PJ; Kwiatkowski, JL; (2010) Symptoms of depression and anxiety in patients with thalassemia: Prevalence and correlates in the thalassemia longitudinal cohort. AM J HEMATOL , 85 (10) 802 - 805. 10.1002/ajh.21826.

Mesri, EA; Cesarman, E; Boshoff, C; (2010) Kaposi's sarcoma and its associated herpesvirus. NAT REV CANCER , 10 (10) 707 - 719. 10.1038/nrc2888.

Meyer, T; Caplin, ME; Palmer, DH; Valle, JW; Larvin, M; Waters, JS; Coxon, F; (2010) A phase Ib/IIa trial to evaluate the CCK2 receptor antagonist Z-360 in combination with gemcitabine in patients with advanced pancreatic cancer. EUR J CANCER , 46 (3) 526 - 533. 10.1016/j.ejca.2009.11.004.

Meyer, T; Roughton, M; Yu, D; Davies, N; Williams, E; Pereira, SP; Hochhauser, D; (2010) A randomized phase II/III trial of three weekly cisplatin based transarterial chemoembolization (TACE) versus embolization (TAE) alone for hepatocellular cancer (HCC). JOURNAL OF CLINICAL ONCOLOGY , 28 (15)

Middleton, MR; Knox, R; Cattell, E; Oppermann, U; Midgley, R; Ali, R; Auton, T; (2010) Quinone Oxidoreductase-2-Mediated Prodrug Cancer Therapy. SCI TRANSL MED , 2 (40) , Article 40ra50. 10.1126/scitranslmed.3000615.

Milojkovic, D; De Melo, VA; Gerrard, G; Goldman, JM; Apperley, JF; Foroni, L; Reid, AG; (2010) EVI-1 oncogene expression predicts survival in chronic phase CML patients resistant to imatinib. In: (Proceedings) 50th Annual Scientific Meeting of the British-Society-for-Haematology. (pp. pp. 22-23). WILEY-BLACKWELL PUBLISHING, INC

Missiaglia, E; Dalai, I; Barbi, S; Beghelli, S; Falconi, M; della Peruta, M; Piemonti, L; (2010) Pancreatic Endocrine Tumors: Expression Profiling Evidences a Role for AKT-mTOR Pathway. J CLIN ONCOL , 28 (2) 245 - 255. 10.1200/JCO.2008.21.5988.

Molife, LR; Fong, PC; Paccagnella, L; Reid, AH; Shaw, HM; Vidal, L; Arkenau, HT; (2010) The insulin-like growth factor-I receptor inhibitor figitumumab (CP-751,871) in combination with docetaxel in patients with advanced solid tumours: results of a phase Ib dose-escalation, open-label study. Br J Cancer , 103 (3) pp. 332-339. 10.1038/sj.bjc.6605767.

Morris, LG; Veeriah, S; Chan, TA; (2010) Genetic determinants at the interface of cancer and neurodegenerative disease. Oncogene , 29 (24) pp. 3453-3464. 10.1038/onc.2010.127.

Moule, R.N.; (2010) CT-PET guided target delineation in head and neck cancer and implications for improved outcome. Doctoral thesis, UCL (University College London). Green open access
file

Muller, MC; Munjal, U; Erben, P; Lion, T; Mitterbauer-Hohendanner, G; El Housni, H; Boeckx, N; (2010) Stability of Conversion Factors for BCR-ABL Monitoring - Implications for the Frequency of Validation Rounds. In: (Proceedings) 52nd Annual Meeting of the American-Society-of-Hematology (ASH). (pp. p. 392). AMER SOC HEMATOLOGY

Mulvey, C; Tudzarova, S; Crawford, M; Williams, GH; Stoeber, K; Godovac-Zimmermann, J; (2010) Quantitative Proteomics Reveals a "Poised Quiescence" Cellular State after Triggering the DNA Replication Origin Activation Checkpoint. Journal of Proteome Research , 9 (10) 5445 - 5460. 10.1021/pr100678k. Green open access
file

Munding, J; Baraniskin, A; Meier, D; Porschen, R; Arkenau, H; Graeven, U; Schulmann, K; (2010) Value of SMAD4 in patients with advanced colorectal cancer (aCRC) receiving an oxaliplatin containing first line chemotherapy - a study of the AIO colorectal cancer group (AIO). ONKOLOGIE , 33 71 - 72.

Munker, R; Liu, CG; Taccioli, C; Alder, H; Heerema, N; (2010) MicroRNA Profiles of Drug-Resistant Myeloma Cell Lines. ACTA HAEMATOL-BASEL , 123 (4) 201 - 204. 10.1159/000302889.

N

Nacheva, EP; Brazma, D; Virgili, A; Howard-Reeves, J; Chanalaris, A; Gancheva, K; Apostolova, M; (2010) Deletions of Immunoglobulin heavy chain and T cell receptor gene regions are uniquely associated with lymphoid blast transformation of chronic myeloid leukemia. BMC GENOMICS , 11 , Article 41. 10.1186/1471-2164-11-41. Green open access
file

Nicol, ED; Schultz, C; Stirrup, J; Roughton, M; Padley, SP; Rubens, MB; Davies, SW; (2010) Defining the appropriate CTA stenosis threshold for gatekeeping to invasive angiography: 50% or 70%? Int J Cardiol , 144 (2) pp. 297-298. 10.1016/j.ijcard.2009.02.031.

Nicol, ED; Stirrup, J; Leatham, E; Roughton, M; Underwood, SR; Padley, SP; Rubens, MB; (2010) Clinical management and short-term cost - 64-slice MDCT vs. myocardial perfusion scintigraphy. Int J Cardiol , 144 (2) pp. 248-250. 10.1016/j.ijcard.2009.01.007.

Northover, J; Glynne-Jones, R; Sebag-Montefiore, D; James, R; Meadows, H; Wan, S; Jitlal, M; (2010) Chemoradiation for the treatment of epidermoid anal cancer: 13-year follow-up of the first randomised UKCCCR Anal Cancer Trial (ACT I). BRITISH JOURNAL OF CANCER , 102 (7) pp. 1123-1128. 10.1038/sj.bjc.6605605.

Northover, J; Glynne-Jones, R; Sebag-Montefiore, D; James, R; Meadows, H; Wan, S; Jitlal, M; (2010) Chemoradiation for the treatment of epidermoid anal cancer: 13-year follow-up of the first randomised UKCCCR Anal Cancer Trial (ACT I). Br J Cancer , 102 (7) pp. 1123-1128. 10.1038/sj.bjc.6605605.

Novakovic, B; Wong, NC; Sibson, M; Ng, HK; Morley, R; Manuelpillai, U; Down, T; (2010) DNA Methylation-mediated Down-regulation of DNA Methyltransferase-1 (DNMT1) Is Coincident with, but Not Essential for, Global Hypomethylation in Human Placenta. J BIOL CHEM , 285 (13) 9583 - 9593. 10.1074/jbc.M109.064956. Gold open access

Novakovic, B.; Wong, N. C.; Sibson, M.; Ng, H.-K.; Morley, R.; Manuelpillai, U.; Down, T.; (2010) DNA methylation-mediated down-regulation of DNA methyltransferase-1 (DNMT1) is coincident with, but not essential for, global hypomethylation in human placenta. Journal of Biological Chemistry , 285 (13) pp. 9583-9593. 10.1074/jbc.M109.064956. Green open access
filefile

Novelli, M; Rossi, S; Rodriguez-Justo, M; Taniere, P; Seddon, B; Toffolatti, L; Sartor, C; (2010) DOG1 and CD117 are the antibodies of choice in the diagnosis of gastrointestinal stromal tumours. Histopathology , 57 (2) pp. 259-270. 10.1111/j.1365-2559.2010.03624.x.

Nutt, JE; Razak, ARA; O'Toole, K; Black, F; Quinn, AE; Calvert, AH; Plummer, ER; (2010) The role of folate receptor alpha (FR alpha) in the response of malignant pleural mesothelioma to pemetrexed-containing chemotherapy. BRIT J CANCER , 102 (3) 553 - 560. 10.1038/sj.bjc.6605501.

O

O'Hanlon, R; Wilson, M; Wage, R; Smith, G; Alpendurada, FD; Wong, J; Dahl, A; (2010) Troponin release following endurance exercise: is inflammation the cause? a cardiovascular magnetic resonance study. Journal of Cardiovascular Magnetic Resonance , 12 , Article 38. 10.1186/1532-429X-12-38. Green open access
file

Oben, J; Patel, T; Mouralidarane, A; Samuelsson, AM; Matthews, P; Pombo, J; Morgan, M; (2010) Maternal obesity programmes offspring development of non-alcoholic fatty pancreas disease. Biochemical and Biophysical Research Communications , 394 (1) 24 - 28. 10.1016/j.bbrc.2010.02.057. Gold open access

Oliveira, JP; Fogo, AB; Bostad, L; Svarstad, E; Cook, WJ; Moll, S; Barbey, F; (2010) SCORING SYSTEM FOR RENAL PATHOLOGY IN FABRY DISEASE: REPORT OF THE INTERNATIONAL STUDY GROUP OF FABRY NEPHROPATHY (ISGFN). In: (Proceedings) 10th Annual European Round Table on Fabry Disease. (pp. S105-S105). ELSEVIER

Ooi, SKT; Wolf, D; Hartung, O; Agarwal, S; Daley, GQ; Goff, SP; Bestor, TH; (2010) Dynamic instability of genomic methylation patterns in pluripotent stem cells. EPIGENET CHROMATIN , 3 , Article 17. 10.1186/1756-8935-3-17. Gold open access

Orikawa, Y; Kato, H; Seto, K; Kobayashi, N; Yoshinaga, K; Hamano, H; Hori, Y; (2010) Z-360, a novel therapeutic agent for pancreatic cancer, prevents up-regulation of ephrin B1 gene expression and phosphorylation of NR2B via suppression of interleukin-1 beta production in a cancer-induced pain model in mice. MOL PAIN , 6 , Article 72. 10.1186/1744-8069-6-72. Gold open access

Osman, LP; Roughton, M; Hodson, ME; Pryor, JA; (2010) Short-term comparative study of high frequency chest wall oscillation and European airway clearance techniques in patients with cystic fibrosis. THORAX , 65 (3) 196 - 200. 10.1136/thx.2008.111492.

P

Patel, B; Aditi, D; Ghorani, E; Malam, Y; Andy, S; Wickremasinghe, R; Lena, R; (2010) Vaccine Measles Virus Has Therapeutic Potential In B Cell Malignancy. In: (Proceedings) 52nd Annual Meeting of the American-Society-of-Hematology (ASH). (pp. p. 1540). AMER SOC HEMATOLOGY

Patel, B; Rai, L; Buck, G; Richards, SM; Mortuza, Y; Mitchell, W; Gerrard, G; (2010) Minimal residual disease is a significant predictor of treatment failure in non T-lineage adult acute lymphoblastic leukaemia: final results of the international trial UKALL XII/ECOG2993. BRIT J HAEMATOL , 148 (1) 80 - 89. 10.1111/j.1365-2141.2009.07941.x.

Pathania, M; Yan, LD; Bordey, A; (2010) A symphony of signals conducts early and late stages of adult neurogenesis. Neuropharmacology , 58 (6) pp. 865-876. 10.1016/j.neuropharm.2010.01.010.

Patkar, V; Acosta, D; Fox, J; Jones, A; Davidson, T; Keshtgar, M; (2010) A novel support tool for Breast Multidisciplinary Meetings: an advanced evidence based computer decision support technology. In: EJC SUPPLEMENTS. (pp. 211 - 211). PERGAMON-ELSEVIER SCIENCE LTD

Peggs, KS; Quezada, SA; (2010) Ipilimumab attenuation of an inhibitory immune checkpoint improves survival in metastatic melanoma. EXPERT REV ANTICANC , 10 (11) 1697 - 1701. 10.1586/ERA.10.144.

Pellagatti, A; Marafioti, T; Paterson, JC; Barlow, JL; Drynan, LF; Giagounidis, A; Pileri, SA; (2010) Induction of p53 and up-regulation of the p53 pathway in the human 5q- syndrome. Blood , 115 (13) pp. 2721-2723. 10.1182/blood-2009-12-259705.

Pennell, D; Porter, J; Cappellini, M; Chan, LL; El-Beshlawy, A; Aydinok, Y; Ibrahim, H; (2010) CONTINUED IMPROVEMENT IN CARDIAC T2*WITH DEFERASIROX TREATMENT OVER 2 YEARS: RESULTS FROM THE EXTENSION OF EPIC CARDIAC SUBSTUDY IN BETA-THALASSAEMIA PATIENTS WITH MYOCARDIAL SIDEROSIS. In: HAEMATOLOGICA-THE HEMATOLOGY JOURNAL. (pp. 202 - 203). FERRATA STORTI FOUNDATION Gold open access

Pennell, D; Porter, J; Cappellini, M; Chan, LL; El-Beshlawy, A; Aydinok, Y; Ibrahim, H; (2010) DEFERASIROX EFFECTIVELY REMOVES CARDIAC IRON IN beta-THALASSAEMIA PATIENTS WITH MYOCARDIAL SIDEROSIS PREVIOUSLY CHELATED WITH DEFEROXAMINE MONOTHERAPY OR DEFEROXAMINE-DEFERIPRONE THERAPY. In: HAEMATOLOGICA-THE HEMATOLOGY JOURNAL. (pp. 699 - 699). FERRATA STORTI FOUNDATION Gold open access

Pennell, DJ; Porter, JB; Cappellini, MD; El-Beshlawy, A; Chan, LL; Aydinok, Y; Elalfy, MS; (2010) Efficacy of deferasirox in reducing and preventing cardiac iron overload in beta-thalassemia. BLOOD , 115 (12) 2364 - 2371. 10.1182/blood-2009-04-217455.

Perry, DJ; Fitzmaurice, DA; Kitchen, S; Mackie, IJ; Mallett, S; (2010) Point-of-care testing in haemostasis. BRIT J HAEMATOL , 150 (5) 501 - 514. 10.1111/j.1365-2141.2010.08223.x.

Peyvandi, F; Palla, R; Lotta, LA; Mackie, I; Scully, MA; Machin, SJ; (2010) ADAMTS-13 assays in thrombotic thrombocytopenic purpura. J THROMB HAEMOST , 8 (4) 631 - 640. 10.1111/j.1538-7836.2010.03761.x.

Pichiorri, F; Suh, SS; Rocci, A; De Luca, L; Taccioli, C; Santhanam, R; Zhou, WC; (2010) Downregulation of p53-inducible microRNAs 192, 194, and 215 Impairs the p53/MDM2 Autoregulatory Loop in Multiple Myeloma Development. CANCER CELL , 18 (4) 367 - 381. 10.1016/j.ccr.2010.09.005.

Pinti, M; Gibellini, L; Guaraldi, G; Orlando, G; Gant, TW; Morselli, E; Nasi, M; (2010) Upregulation of nuclear-encoded mitochondrial LON protease in HAART-treated HIV-positive patients with lipodystrophy: implications for the pathogenesis of the disease. AIDS , 24 (6) 841 - 850. 10.1097/QAD.0b013e32833779a3.

Porter, DL; Alyea, EP; Antin, JH; DeLima, M; Estey, E; Falkenburg, JHF; Hardy, N; (2010) NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation. BIOL BLOOD MARROW TR , 16 (11) 1467 - 1503. 10.1016/j.bbmt.2010.08.001.

Porter, JB; Shah, FT; (2010) Iron Overload in Thalassemia and Related Conditions: Therapeutic Goals and Assessment of Response to Chelation Therapies. HEMATOL ONCOL CLIN N , 24 (6) 1109 - +. 10.1016/j.hoc.2010.08.015.

Prando, C; Boisson-Dupuis, S; Grant, AV; Kong, XF; Bustamante, J; Feinberg, J; Chapgier, A; (2010) Paternal uniparental isodisomy of chromosome 6 causing a complex syndrome including complete IFN-gamma receptor 1 deficiency. Am J Med Genet A , 152A (3) pp. 622-629. 10.1002/ajmg.a.33291.

Presneau, N; Eskandarpour, M; Idowu, B; Halal, D; Coulter, E; Henderson, S; Tirabosco, R; (2010) MicroRNA deregulation in peripheral nerve sheath tumor progression. JOURNAL OF CLINICAL ONCOLOGY , 28 (15)

Proctor, I; Rodriguez-Acebes, S; Loddo, M; Wollenschlaeger, A; Falzon, M; Prevost, A; Sainsbury, R; (2010) Targeting DNA Replication Before it Starts: Cdc7 as a Therapeutic Target in p53-Mutant Breast Cancer. In: JOURNAL OF PATHOLOGY. (pp. S20 - S20). JOHN WILEY & SONS LTD

Proctor, I; Stoeber, K; Williams, GH; (2010) Biomarkers in bladder cancer. HISTOPATHOLOGY , 57 (1) 1 - 13. 10.1111/j.1365-2559.2010.03592.x.

Prokopowicz, ZM; Arce, F; Biedron, R; Chiang, CLL; Ciszek, M; Katz, DR; Nowakowska, M; (2010) Hypochlorous Acid: A Natural Adjuvant That Facilitates Antigen Processing, Cross-Priming, and the Induction of Adaptive Immunity. J IMMUNOL , 184 (2) 824 - 835. 10.4049/jimmunol.0902606.

Pyo, C-W; Guethlein, LA; Vu, Q; Wang, R; Abi-Rached, L; Norman, PJ; Marsh, SGE; (2010) Different Patterns of Evolution in the Centromeric and Telomeric Regions of Group A and B Haplotypes of the Human Killer Cell Ig-Like Receptor Locus. PLOS ONE , 5 (12) 10.1371/journal.pone.0015115. Gold open access

Q

Quezada, SA; Simpson, TR; Peggs, KS; Merghoub, T; Vider, J; Fan, XZ; Blasberg, R; (2010) Tumor-reactive CD4(+) T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts. J EXP MED , 207 (3) 637 - 650. 10.1084/jem.20091918.

Quinn, J; Percy, L; Glassford, J; Somana, K; Rodriguez-Justo, M; Yong, K; (2010) CD20-positive multiple myeloma - differential expression of cyclins D1 and D2 suggests a heterogeneous disease. BRIT J HAEMATOL , 149 (1) 156 - 159. 10.1111/j.1365-2141.2009.08030.x.

R

Rai, L; Casanova, A; Moorman, AV; Richards, S; Buck, G; Goldstone, AH; Fielding, AK; (2010) Antigen receptor gene rearrangements reflect on the heterogeneity of adult Acute Lymphoblastic Leukaemia (ALL) with implications of cell-origin of ALL subgroups - a UKALLXII study. Br J Haematol , 148 (3) pp. 394-401. 10.1111/j.1365-2141.2009.07966.x.

Ramadani, F; Bolland, DJ; Garcon, F; Emery, JL; Vanhaesebroeck, B; Corcoran, AE; Okkenhaug, K; (2010) The PI3K isoforms p110alpha and p110delta are essential for pre-B cell receptor signaling and B cell development. Sci Signal , 3 (134) ra60-. 10.1126/scisignal.2001104.

Reichold, M; Zdebik, AA; Lieberer, E; Rapedius, M; Schmidt, K; Bandulik, S; Sterner, C; (2010) KCNJ10 gene mutations causing EAST syndrome (epilepsy, ataxia, sensorineural deafness, and tubulopathy) disrupt channel function. P NATL ACAD SCI USA , 107 (32) 14490 - 14495. 10.1073/pnas.1003072107.

Roberts, CH; Mayor, NP; Madrigal, JA; Marsh, SGE; (2010) Short template amplicon and multiplex megaprimer-enabled relay (STAMMER) sequencing, a simultaneous approach to higher throughput sequence-based typing of polymorphic genes. IMMUNOGENETICS , 62 (4) pp. 253-260. 10.1007/s00251-010-0432-5.

Robinson, J; Mistry, K; McWilliam, H; Lopez, R; Marsh, SGE; (2010) IPD-the Immuno Polymorphism Database. NUCLEIC ACIDS RESEARCH , 38 D863-D869. 10.1093/nar/gkp879.

Rodig, SJ; Kutok, JL; Paterson, JC; Nitta, H; Zhang, W; Chapuy, B; Tumwine, LK; (2010) The pre-B-cell receptor associated protein VpreB3 is a useful diagnostic marker for identifying c-MYC translocated lymphomas. Haematologica , 95 (12) pp. 2056-2062. 10.3324/haematol.2010.025767.

Rodriguez-Acebes, S; Proctor, I; Loddo, M; Wollenschlaeger, A; Rashid, M; Falzon, M; Prevost, AT; (2010) Targeting DNA Replication before it Starts Cdc7 as a Therapeutic Target in p53-Mutant Breast Cancers. AM J PATHOL , 177 (4) 2034 - 2045. 10.2353/ajpath.2010.100421.

S

Saewong, T; Ounjaijean, S; Mundee, Y; Pattanapanyasat, K; Fucharoen, S; Porter, JB; Srichairatanakool, S; (2010) Effects of Green Tea on Iron Accumulation and Oxidative Stress in Livers of Iron-Challenged Thalassemic Mice. MED CHEM , 6 (2) 57 - 64.

Sainsbury, R; Proctor, I; Rodriguez, S; Loddo, M; Tudzarova, S; Stoeber, K; Williams, G; (2010) Targeting DNA replication before it starts: Cdc7 as a therapeutic target in p53 mutant Her2 and triple negative breast cancer. In: BREAST CANCER RESEARCH. (pp. S15 - S16). BIOMED CENTRAL LTD

Salomoni, P; Basu, S; Tavassoli, M; Watson, CJ; (2010) The Siren's Song: a new book on the perils and benefits of (cell) death. Cell Death Dis , 1 (5) , Article e39. 10.1038/cddis.2010.13. Gold open access

Salomoni, P; Calegari, F; (2010) Calcium oscillations, G1 phase duration and neurogenesis timing Response. TRENDS CELL BIOL , 20 (10) 578 - 578. 10.1016/j.tcb.2010.07.003.

Salomoni, P; Calegari, F; (2010) Cell cycle control of mammalian neural stem cells: putting a speed limit on G1. TRENDS CELL BIOL , 20 (5) 233 - 243. 10.1016/j.tcb.2010.01.006.

Samarasinghe, S; Mancao, C; Pule, M; Nawroly, N; Karlsson, H; Brewin, J; Openshaw, P; (2010) Functional characterization of alloreactive T cells identifies CD25 and CD71 as optimal targets for a clinically applicable allodepletion strategy. BLOOD , 115 (2) 396 - 407. 10.1182/blood-2009-08-235895.

Scaffidi, P; Misteli, T; (2010) Cancer epigenetics: from disruption of differentiation programs to the emergence of cancer stem cells. Cold Spring Harb Symp Quant Biol , 75 pp. 251-258. 10.1101/sqb.2010.75.007.

Schellekens, J; Schaffer, M; Malmberg, K-J; Madrigal, JA; Marsh, SGE; (2010) Identification of a novel KIR3DL1*072 allele by sequence-based typing. TISSUE ANTIGENS , 76 (1) pp. 74-75. 10.1111/j.1399-0039.2010.01464.x.

Scully, M; Brown, J; Patel, R; McDonald, V; Brown, CJ; Machin, S; (2010) Human leukocyte antigen association in idiopathic thrombotic thrombocytopenic purpura: evidence for an immunogenetic link. J THROMB HAEMOST , 8 (2) 257 - 262. 10.1111/j.1538-7836.2009.03692.x.

Scully, M; Cavenagh, JD; Hunt, B; McDonald, V; Machin, SJ; (2010) A Phase II Study to Assess the Safety, Efficacy and Tolerability of Rituximab (Mabthera) In Combination with Plasma Exchange In Patients with Acute Thrombotic Thrombocytopenic Purpura (TTP). In: BLOOD. (pp. 1518 - 1518). AMER SOC HEMATOLOGY

Scully, M; Cavenagh, JD; Hunt, B; McDonald, V; Machin, SJ; (2010) A Phase II Study to Assess the Safety, Efficacy and Tolerability of Rituximab (Mabthera) In Combination with Plasma Exchange In Patients with Acute Thrombotic Thrombocytopenic Purpura (TTP). In: BLOOD. (pp. 1518 - 1518). AMER SOC HEMATOLOGY

Sellar, RS; Corbett, EL; D'Sa, S; Linch, DC; Ardeshna, KM; (2010) Lesson of the Week Treatment for lymph node tuberculosis. BRIT MED J , 340 , Article c63. 10.1136/bmj.c63.

Severin, J; Beal, K; Vilella, AJ; Fitzgerald, S; Schuster, M; Gordon, L; Ureta-Vidal, A; (2010) eHive: an artificial intelligence workflow system for genomic analysis. BMC Bioinformatics , 11 240-. 10.1186/1471-2105-11-240.

Shaw, BE; (2010) First do no harm. BLOOD , 115 (24) 4978 - 4979.

Shaw, BE; Arguello, R; Garcia-Sepulveda, CA; Madrigal, JA; (2010) The impact of HLA genotyping on survival following unrelated donor haematopoietic stem cell transplantation. BRIT J HAEMATOL , 150 (3) 251 - 258. 10.1111/j.1365-2141.2010.08224.x.

Shaw, BE; Ball, L; Beksac, M; Bengtsson, M; Confer, D; Diler, S; Fechter, M; (2010) Donor safety: the role of the WMDA in ensuring the safety of volunteer unrelated donors: clinical and ethical considerations. BONE MARROW TRANSPL , 45 (5) 832 - 838. 10.1038/bmt.2010.2.

Shaw, BE; Mayor, NP; Russell, NH; Apperley, JF; Clark, RE; Cornish, J; Darbyshire, P; (2010) Diverging effects of HLA-DPB1 matching status on outcome following unrelated donor transplantation depending on disease stage and the degree of matching for other HLA alleles. LEUKEMIA , 24 (1) 58 - 65. 10.1038/leu.2009.239.

Shaw, BE; Mayor, NP; Russell, NH; Apperley, JF; Clark, RE; Cornish, J; Darbyshire, P; (2010) Diverging effects of HLA-DPB1 matching status on outcome following unrelated donor transplantation depending on disease stage and the degree of matching for other HLA alleles. pp. 58-65.

Silvanto, AM; Melly, L; Hannan, SA; Kocjan, G; (2010) FNAC of nodular fasciitis mimicking a pleomorphic adenoma: another diagnostic pitfall. CYTOPATHOLOGY , 21 (4) 276 - 277. 10.1111/j.1365-2303.2009.00706.x.

Sims, TL; McGee, M; Williams, RF; Myers, AL; Tracey, L; Hamner, JB; Ng, C; (2010) IFN-β restricts tumor growth and sensitizes alveolar rhabdomyosarcoma to ionizing radiation. Molecular Cancer Therapeutics , 9 (3) pp. 761-771. 10.1158/1535-7163.MCT-09-0800.

Smrt, RD; Szulwach, KE; Pfeiffer, RL; Li, X; Guo, W; Pathania, M; Teng, ZQ; (2010) MicroRNA miR-137 regulates neuronal maturation by targeting ubiquitin ligase mind bomb-1. Stem Cells , 28 (6) pp. 1060-1070. 10.1002/stem.431.

Spanswick, VJ; Hartley, JM; Hartley, JA; (2010) Measurement of DNA interstrand crosslinking in individual cells using the Single Cell Gel Electrophoresis (Comet) assay. Methods Mol Biol , 613 pp. 267-282. 10.1007/978-1-60327-418-0_17.

Sparapani, S; Bellini, S; Gunaratnam, M; Haider, SM; Andreani, A; Rambaldi, M; Locatelli, A; (2010) Bis-guanylhydrazone diimidazo[1,2-a:1,2-c]pyrimidine as a novel and specific G-quadruplex binding motif. Chem Commun (Camb) , 46 (31) pp. 5680-5682. 10.1039/c0cc00020e.

Sparapani, S; Haider, SM; Doria, F; Gunaratnam, M; Neidle, S; (2010) Rational design of acridine-based ligands with selectivity for human telomeric quadruplexes. J Am Chem Soc , 132 (35) pp. 12263-12272. 10.1021/ja1003944.

Speyer, BE; Pizzey, AR; Ranieri, M; Joshi, R; Delhanty, JDA; Serhal, P; (2010) Fall in implantation rates following ICSI with sperm with high DNA fragmentation. HUMAN REPRODUCTION , 25 (7) pp. 1609-1618. 10.1093/humrep/deq116.

Srirajaskanthan, R; Caplin, ME; Waugh, MG; Watkins, J; Meyer, T; Hsuan, JJ; Beaumont, NJ; (2010) Identification of Mac-2-binding Protein as a Putative Marker of Neuroendocrine Tumors from the Analysis of Cell Line Secretomes. MOL CELL PROTEOMICS , 9 (4) 656 - 666. 10.1074/mcp.M900401-MCP200.

Steele, AJ; Prentice, AG; Cwynarski, K; Hoffbrand, AV; Hart, SM; Lowdell, MW; Samuel, ER; (2010) The JAK3-selective inhibitor PF-956980 reverses the resistance to cytotoxic agents induced by interleukin-4 treatment of chronic lymphocytic leukemia cells: potential for reversal of cytoprotection by the microenvironment. BLOOD , 116 (22) 4569 - 4577. 10.1182/blood-2009-09-245811.

Strauss, SJ; Ng, T; Mendoza-Naranjo, A; Whelan, J; Sorensen, PHB; (2010) Understanding Micrometastatic Disease and Anoikis Resistance in Ewing Family of Tumors and Osteosarcoma. ONCOLOGIST , 15 (6) 627 - 635. 10.1634/theoncologist.2010-0093.

Strenger, V; Aberle, SW; Wendelin, G; Pfurtscheller, K; Nacheva, EP; Zobel, G; Nagel, B; (2010) Chromosomal integration of the HHV-6 genome as a possible cause of HHV-6 detection in cardiac tissues. J CLIN PATHOL , 63 (12) 1129 - 1130. 10.1136/jcp.2010.079277.

Stringaris, K; Barrett, AJ; Hills, R; Linch, DC; Gale, R; Allen, C; Garland, P; (2010) A Distinct Signature of Natural Killer Cell MR Gene Frequencies In Secondary AML Compared with De Novo AML and Normal Controls. In: BLOOD. (pp. 711 - 712). AMER SOC HEMATOLOGY

T

Taher, A; Elalfy, M; El-Beshlawy, A; Zhou, D; Chan, LL; Li, CK; Lin, KH; (2010) EFFICACY, PATIENT SATISFACTION AND ADHERENCE TO TREATMENT WITH DEFERASIROX DOSES OF=30 MG/KG/DAY IN PREVIOUSLY CHELATED IRON-OVERLOADED PATIENTS WITH BETA-THALASSAEMIA MAJOR. In: HAEMATOLOGICA-THE HEMATOLOGY JOURNAL. (pp. 709 - 709). FERRATA STORTI FOUNDATION Gold open access

Tatevossian, RG; Lawson, AR; Forshew, T; Hindley, GF; Ellison, DW; Sheer, D; (2010) MAPK pathway activation and the origins of pediatric low-grade astrocytomas. J Cell Physiol , 222 (3) pp. 509-514. 10.1002/jcp.21978.

Tatevossian, RG; Tang, B; Dalton, J; Forshew, T; Lawson, AR; Ma, J; Neale, G; (2010) MYB upregulation and genetic aberrations in a subset of pediatric low-grade gliomas. Acta Neuropathol , 120 (6) pp. 731-743. 10.1007/s00401-010-0763-1.

Tavora, B; Batista, S; Reynolds, LE; Jadeja, S; Robinson, S; Kostourou, V; Hart, I; (2010) Endothelial FAK is required for tumour angiogenesis. EMBO MOLECULAR MEDICINE , 2 (12) pp. 516-528. 10.1002/emmm.201000106. Gold open access

Taylor, RM; Franck, LS; Dhawan, A; Gibson, F; (2010) The Stories of Young People Living With a Liver Transplant. QUAL HEALTH RES , 20 (8) 1076 - 1090. 10.1177/1049732310368405.

Taylor, RM; Wray, J; Gibson, F; (2010) Measuring quality of life in children and young people after transplantation: Methodological considerations. PEDIATR TRANSPLANT , 14 (4) 445 - 458. 10.1111/j.1399-3046.2010.01316.x.

Teschendorff, AE; Menon, U; Gentry-Maharaj, A; Ramus, SJ; Weisenberger, DJ; Shen, H; Campan, M; (2010) Age-dependent DNA methylation of genes that are suppressed in stem cells is a hallmark of cancer. GENOME RES , 20 (4) 440 - 446. 10.1101/gr.103606.109.

Thirlwell, C; Eymard, M; Feber, A; Teschendorff, A; Pearce, K; Lechner, M; Widschwendter, M; (2010) Genome-wide DNA methylation analysis of archival formalin-fixed paraffin-embedded tissue using the Illumina Infinium HumanMethylation27 BeadChip. METHODS , 52 (3) 248 - 254. 10.1016/j.ymeth.2010.04.012.

Thirlwell, C; Will, OCC; Domingo, E; Graham, TA; McDonald, SAC; Oukrif, D; Jeffrey, R; (2010) Clonality Assessment and Clonal Ordering of Individual Neoplastic Crypts Shows Polyclonality of Colorectal Adenomas. GASTROENTEROLOGY , 138 (4) 1441 - U298. 10.1053/j.gastro.2010.01.033.

Thomas, AS; Garbowski, M; Ang, AL; Shah, FT; Walker, JM; Moon, JC; Pennell, DJ; (2010) A Decade Follow-up of a Thalassemia Major (TM) Cohort Monitored by Cardiac Magnetic Resonance Imaging (CMR): Significant Reduction In Patients with Cardiac Iron and In Total Mortality. In: BLOOD. (pp. 444 - 445). AMER SOC HEMATOLOGY

Thomson, G; Marthandan, N; Hollenbach, JA; Mack, SJ; Erlich, HA; Single, RM; Waller, MJ; (2010) Sequence feature variant type (SFVT) analysis of the HLA genetic association in juvenile idiopathic arthritis. Pac Symp Biocomput pp. 359-370.

Thomson, KJ; Morris, EC; Milligan, D; Parker, AN; Hunter, AE; Cook, G; Bloor, AJC; (2010) T-Cell-Depleted Reduced-Intensity Transplantation Followed by Donor Leukocyte Infusions to Promote Graft-Versus-Lymphoma Activity Results in Excellent Long-Term Survival in Patients With Multiply Relapsed Follicular Lymphoma. J CLIN ONCOL , 28 (23) 3695 - 3700. 10.1200/JCO.2009.26.9100.

Tili, E; Michaille, JJ; Adair, B; Alder, H; Limagne, E; Taccioli, C; Ferracin, M; (2010) Resveratrol decreases the levels of miR-155 by upregulating miR-663, a microRNA targeting JunB and JunD. CARCINOGENESIS , 31 (9) 1561 - 1566. 10.1093/carcin/bgq143.

Tili, E; Michaille, JJ; Liu, CG; Alder, H; Taccioli, C; Volinia, S; Calin, GA; (2010) GAM/ZFp/ZNF512B is central to a gene sensor circuitry involving cell-cycle regulators, TGF beta effectors, Drosha and microRNAs with opposite oncogenic potentials. NUCLEIC ACIDS RES , 38 (21) 7673 - 7688. 10.1093/nar/gkq637. Gold open access

Tirabosco, R; Galloway, M; Bradford, R; O'Donnell, P; Flanagan, AM; (2010) Liposarcomatous differentiation in malignant peripheral nerve sheath tumor: A case report. PATHOL RES PRACT , 206 (2) 138 - 142. 10.1016/j.prp.2009.04.005.

Tracey, L; Streck, CJ; Du, Z; Williams, RF; Pfeffer, LM; Nathwani, AC; Davidoff, AM; (2010) NF-kappa B activation mediates resistance to IFN beta in MLL-rearranged acute lymphoblastic leukemia. LEUKEMIA , 24 (4) 806 - 812. 10.1038/leu.2010.2.

Tracey, L; Streck, CJ; Du, Z; Williams, RF; Pfeffer, LM; Nathwani, AC; Davidoff, AM; (2010) NF-κB activation mediates resistance to IFNΒ in MLL-rearranged acute lymphoblastic leukemia. Leukemia , 24 (4) pp. 806-812. 10.1038/leu.2010.2.

Trimble, EL; Birrer, MJ; Hoskins, WJ; Marth, C; Petryshyn, R; Quinn, M; Thomas, GM; (2010) Current academic clinical trials in ovarian cancer: Gynecologic Cancer Intergroup and US National Cancer Institute Clinical Trials Planning Meeting, May 2009. Int J Gynecol Cancer , 20 (7) pp. 1290-1298. 10.1111/IGC.0b013e3181ee1c01.

Tsochatzis, E; Garcovich, M; Marelli, L; Fede, G; Germani, G; Manousou, P; Arvaniti, V; (2010) TRANSARTERIAL CHEMOEMBOLIZATION AS NEO-ADJUVANT THERAPY PRE-TRANSPLANTATION IN PATIENTS WITH HEPATOCELLULAR CARCINOMA. In: (Proceedings) 61st Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases. (pp. 858A-859A). WILEY-BLACKWELL

Tsochatzis, E; Meyer, T; Marelli, L; Burroughs, AK; (2010) Which transarterial therapy is best for hepatocellular carcinoma? - The evidence to date. J HEPATOL , 53 (3) 588 - 588.

Tudzarova, S; Trotter, MWB; Wollenschlager, A; Mulvey, C; Godovac-Zimmermann, J; Williams, G; Stoeber, K; (2010) Molecular Architecture of the DNA Replication Origin Activation Checkpoint. EMBO Journal , 29 (19) 3381 - 3394. 10.1038/emboj.2010.201. Green open access
file

Turner, NC; Strauss, SJ; Sarker, D; Gillmore, R; Kirkwood, A; Hackshaw, A; Papadopoulou, A; (2010) Chemotherapy with 5-fluorouracil, cisplatin and streptozocin for neuroendocrine tumours. BRIT J CANCER , 102 (7) 1106 - 1112. 10.1038/sj.bjc.6605618.

U

Ueda, T; Volinia, S; Okumura, H; Shimizu, M; Taccioli, C; Rossi, S; Alder, H; (2010) Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis. LANCET ONCOL , 11 (2) 136 - 146. 10.1016/S1470-2045(09)70343-2.

Uno, JK; Rao, KN; Matsuoka, K; Sheikh, SZ; Kobayashi, T; Li, F; Steinbach, EC; (2010) Altered macrophage function contributes to colitis in mice defective in the phosphoinositide-3 kinase subunit p110δ. Gastroenterology , 139 (5) 1642-1653.e6. 10.1053/j.gastro.2010.07.008.

Utting, JC; Flanagan, AM; Brandao-Burch, A; Orriss, IR; Arnett, TR; (2010) Hypoxia stimulates osteoclast formation from human peripheral blood. CELL BIOCHEMISTRY AND FUNCTION , 28 (5) pp. 374-380. 10.1002/cbf.1660.

V

Valle, J; Wasan, H; Palmer, DH; Cunningham, D; Anthoney, A; Maraveyas, A; Madhusudan, S; (2010) Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer. NEW ENGL J MED , 362 (14) 1273 - 1281.

Vanhaesebroeck, B; Guillermet-Guibert, J; Graupera, M; Bilanges, B; (2010) The emerging mechanisms of isoform-specific PI3K signalling. Nat Rev Mol Cell Biol , 11 (5) pp. 329-341. 10.1038/nrm2882.

Vanhaesebroeck, B; Vogt, PK; Rommel, C; (2010) PI3K: from the bench to the clinic and back. Curr Top Microbiol Immunol , 347 pp. 1-19. 10.1007/82_2010_65.

Vanrobays, E; Jennings, BH; Ish-Horowicz, D; (2010) Identification and mapping of induced chromosomal deletions using sequence polymorphisms. Biotechniques , 48 (1) pp. 53-60. 10.2144/000113348.

Veeriah, S; Morris, L; Solit, D; Chan, TA; (2010) The familial Parkinson disease gene PARK2 is a multisite tumor suppressor on chromosome 6q25.2-27 that regulates cyclin E. Cell Cycle , 9 (8) pp. 1451-1452. 10.4161/cc.9.8.11583.

Veeriah, S; Taylor, BS; Meng, S; Fang, F; Yilmaz, E; Vivanco, I; Janakiraman, M; (2010) Somatic mutations of the Parkinson's disease-associated gene PARK2 in glioblastoma and other human malignancies. Nat Genet , 42 (1) pp. 77-82. 10.1038/ng.491.

Vezzalini, M; Aletta, JM; Beghelli, S; Moratti, E; Della Peruta, M; Mafficini, A; Mojica, WD; (2010) Immunohistochemical detection of arginine methylated proteins (MeRP) in archival tissues. Histopathology , 57 (5) pp. 725-733. 10.1111/j.1365-2559.2010.03684.x.

Vigor, K.L.; (2010) Antibody targeted nanoparticles for imaging and therapy of cancer. Doctoral thesis, UCL (University College London). Green open access
file

Vigor, KL; Kyrtatos, PG; Minogue, S; Al-Jamal, KT; Kogelberg, H; Tolner, B; Kostarelos, K; (2010) Nanoparticles functionalised with recombinant single chain Fv antibody fragments (scFv) for the magnetic resonance imaging of cancer cells. BIOMATERIALS , 31 (6) 1307 - 1315. 10.1016/j.biomaterials.2009.10.036.

Virgili, A; Nacheva, EP; (2010) Genomic amplification of BCR/ABL1 and a region downstream of ABL1 in chronic myeloid leukaemia: a FISH mapping study of CML patients and cell lines. Molecular Cytogenetics , 3 , Article 15. 10.1186/1755-8166-3-15. Green open access
file

Volinia, S; Galasso, M; Costinean, S; Tagliavini, L; Gamberoni, G; Drusco, A; Marchesini, J; (2010) Reprogramming of miRNA networks in cancer and leukemia. GENOME RES , 20 (5) 589 - 599. 10.1101/gr.098046.109.

Vozzolo, L; Loh, B; Gane, PJ; Tribak, M; Zhou, LH; Anderson, I; Nyakatura, E; (2010) Gyrase B Inhibitor Impairs HIV-1 Replication by Targeting Hsp90 and the Capsid Protein. J BIOL CHEM , 285 (50) 39314 - 39328. 10.1074/jbc.M110.155275. Gold open access

van Walraven, SM; Nicoloso-de Faveri, G; Axdorph-Nygell, UAI; Douglas, KW; Jones, DA; Lee, SJ; Pulsipher, M; (2010) Family donor care management: principles and recommendations. BONE MARROW TRANSPL , 45 (8) 1269 - 1273. 10.1038/bmt.2009.354.

W

Waldmeier, F; Bruin, GJ; Glaenzel, U; Hazell, K; Sechaud, R; Warrington, S; Porter, JB; (2010) Pharmacokinetics, Metabolism, and Disposition of Deferasirox in beta-Thalassemic Patients with Transfusion-Dependent Iron Overload Who Are at Pharmacokinetic Steady State. DRUG METAB DISPOS , 38 (5) 808 - 816. 10.1124/dmd.109.030833.

Walker, RJE; Toumpanakis, C; Marelli, L; Yu, D; Davies, N; Woodward, N; Goode, A; (2010) Transarterial embolization/chemoebolization for hepatic NET metastases: recent efficacy and toxicity data. In: (Proceedings) 18th International Symposium on Regulatory Peptides. (pp. p. 6). ELSEVIER SCIENCE BV

Walton, JA; Lydyard, PM; Nathwani, A; Emery, V; Akbar, A; Glennie, MJ; Porakishvili, N; (2010) Patients with B cell chronic lymphocytic leukaemia have an expanded population of CD4+perforin expressing T cells enriched for human cytomegalovirus specificity and an effector-memory phenotype